WO2005004601A1 - Secondary alcohols used as antimicrobial agents - Google Patents

Secondary alcohols used as antimicrobial agents Download PDF

Info

Publication number
WO2005004601A1
WO2005004601A1 PCT/EP2004/051078 EP2004051078W WO2005004601A1 WO 2005004601 A1 WO2005004601 A1 WO 2005004601A1 EP 2004051078 W EP2004051078 W EP 2004051078W WO 2005004601 A1 WO2005004601 A1 WO 2005004601A1
Authority
WO
WIPO (PCT)
Prior art keywords
compound
butanol
methyl
gram
formula
Prior art date
Application number
PCT/EP2004/051078
Other languages
German (de)
French (fr)
Inventor
Aurelia Reckziegel
Horst Surburg
Florian Wolf
Jürgen Rabenhorst
Original Assignee
Symrise Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symrise Gmbh & Co. Kg filed Critical Symrise Gmbh & Co. Kg
Priority to EP04741770A priority Critical patent/EP1651037A1/en
Publication of WO2005004601A1 publication Critical patent/WO2005004601A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/04Oxygen or sulfur attached to an aliphatic side-chain of a carbocyclic ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/18Monohydroxylic alcohols containing only six-membered aromatic rings as cyclic part
    • C07C33/20Monohydroxylic alcohols containing only six-membered aromatic rings as cyclic part monocyclic

Definitions

  • the present invention relates to the use of certain secondary alcohols as active ingredients against Gram-positive bacteria, as are particularly responsible for (a) body odor, (b) impure skin and / or acne, and (c) bad breath and / or bad breath.
  • Some of the compounds that can be used according to the invention are new, as are the preparations in which they are used.
  • the healthy warm-blooded organism especially the healthy human skin and mucous membrane, is populated with a large number of non-pathogenic microorganisms.
  • This so-called microflora of the skin or mucous membrane is not only harmless, it represents an important protection for the defense against opportunistic or pathogenic germs.
  • other microorganisms can improve the condition of the healthy ones
  • antimicrobial agents are sought, the antibacterial spectrum (antibiogram) of which includes Gram-positive bacteria. It is already known that certain alcohols have an antimicrobial effect.
  • primary alcohols such as. B. Famesol, a primary sesquiterpene alcohol.
  • farnesol and other primary alcohols with antimicrobial properties have a sensitizing and allergenic potential, so that their use is increasingly no longer tolerated.
  • the primary object of the present invention to provide compounds which are active against Gram-positive bacteria.
  • the compounds to be specified should have a possibly slight intrinsic odor, be easy to incorporate into antibacterial preparations, be stable in the usual cosmetic formulations and also under the required application conditions, and be readily accessible, ie. H. be producible by simple chemical reactions and be well tolerated, d. H. do not cause unacceptable health effects when used-
  • R 1 to R 6 are independently hydrogen or methyl
  • A is a phenyl group optionally substituted with a further C, - to C 5 - substituted alkyl substituents, a norbornane-2-yl or a Pina ⁇ - 3-yl-Gr ⁇ ppe.
  • the alcohols to be used according to the invention are secondary alcohols which comprise an aryl radical (group A).
  • group A an aryl radical
  • WO 01/85120 A1 relates to the use of the secondary alcohol 6,10-dimethyI-5,9-undecadien-2-ol as an antimicrobial active ingredient, it also gives no indication of the usability of secondary alcohols which come under the formula I.
  • DE 100 25 124 A1 describes combinations of active ingredients which comprise a glycerol monoalkyl ether and an aryl-substituted alcohol. It is not excluded that the glycerol monoalkyl ether is combined with a secondary aryl-substituted alcohol, but the primary alcohols phenoxyethanoi, anise alcohol and 2-methyl-5-phenyl-pentan-1-ol and the tertiary alcohol phenyl-dimethylethylcarbonol are particularly preferred , It is not disclosed that aryl-substituted alcohols alone can have an effect against Gram-positive bacteria, and this applies in particular to aryl-substituted secondary alcohols.
  • EP 0 919 607 A2 discloses additives for the physical and / or microbiological stabilization of the liquid or viscous composition of a lubricant, the additive being an aromatic alcohol, which can also be secondary. However, it is not disclosed which germs the additive should be effective against; however, it is generally stated that
  • Cooling lubricant compositions are microbiologically stabilized. However, since cooling lubricants are usually only colonized by bacteria that are Gram-negative, EP 0 919 607 A2 at least gives no indication that they are used as an additive
  • the compounds of the formula I to be used according to the invention have a very excellent activity against Having Gram-positive bacteria
  • the compounds of the formula I are particularly suitable because they have at most a low intrinsic odor and can be prepared by simple chemical reactions.
  • the secondary alcohols of the formula I are active substances against Gram-positive bacteria in particular can be used in cosmetic, oral hygiene and / or dermatological preparations
  • Gram-positive bacteria are known to the person skilled in the art, which are responsible for the unpleasant body conditions according to (a) - (c).
  • Gram-positive bacteria that cause body odor are bacteria e.g. B. from the genera Corynebacterium, Staphyiococcus, Micrococcus and Brevibacterium, in particular Corynebacterium xerosis, Staphyiococcus epidermidis and Staphyiococcus hominis, Micrococcus luteus and / or Micrococcus sedentarius and Brevibacterium epidermidis.
  • Gram-positive bacteria that verusache ⁇ impure skin and / or acne are, for example, bacteria of the genus Propionibacterium, in particular Propionibacterium acnes.
  • Gram-positive bacteria that cause bad breath and / or bad breath are, for example, bacteria of the genera Actinomyces, Eubacterium, Rothia and Stomatococcus, in particular Actinomyces viscosus, Eubacterium brachy, Eubacterium nodatum, Eubacterium saburreum, Eubacterium timidum and Eubacterium denticus and Roth Stomatococcus mucilaginosus.
  • the secondary alcohols of formula (!) Harmonize with a variety of common cosmetic auxiliaries and additives.
  • the compounds of formula I can therefore be incorporated into a wide variety of dosage forms and preparations. Preparations to be applied to the skin which contain compounds of the formula I are able to determine the number of Gram-positive bacteria responsible for the respective phenomenon or the particular impairment according to the above
  • Enumeration (a) to (c) are responsible for reducing, while the microflora of the contacted skin is protected.
  • Preparations which contain the compounds of the formula I are regularly distinguished by good skin tolerance, provided that none of the other constituents contained in the preparation cause an intolerance.
  • deodorants especially those against body odor and bad breath, which contain the secondary alcohols of the formula I.
  • deodorants have good skin tolerance (including
  • group A is preferably phenyl, 2-methylphenyl, 3-methylphenyl, 4-methylphenyl, 4-isopropylphenyl, 4-tert-butylphenyl, 4-isobutylphenyl, 2,4-dimethylphenyl, 3,4 -Dimethyiphenyl, 2,5-dimethylphenyl, 2,4,5-trimethylphenyl, 2,4,6-trimethylphenyl,
  • At least one of the groups R 1 to R ⁇ is methyl if A is phenyl or a monoalkyl-substituted phenyl.
  • the following compounds of the formula I are particularly preferred as active substances against Gram-positive bacteria:
  • the invention also relates to methods for controlling Gram-positive bacteria, the bacteria being contacted with an antimicrobially effective amount of a compound of the formula I or a mixture of at least two different compounds of the formula I.
  • the compounds of the formula I mentioned above apply here Meanings of the substituents, the information relating to the particularly preferred compounds of the formula I of course also continuing to apply.
  • the invention also relates to a method for controlling (a) body odor caused by Gram-positive bacteria (b) impure skin and / or acne caused by Gram-positive bacteria and / or (c) bad breath caused by Gram-positive bacteria and / or bad breath, the Gram-positive bacteria being contacted with an antimicrobially effective amount of a compound of the formula I or a mixture of at least two different compounds of the formula I.
  • a method for controlling (a) body odor caused by Gram-positive bacteria (b) impure skin and / or acne caused by Gram-positive bacteria and / or (c) bad breath caused by Gram-positive bacteria and / or bad breath, the Gram-positive bacteria being contacted with an antimicrobially effective amount of a compound of the formula I or a mixture of at least two different compounds of the formula I.
  • the compound of the formula I is usually applied flat to the area of the skin (including the mucous membrane)
  • control encompasses both the treatment of existing impairments (in particular by undesirable, bacterially caused odors) and the corresponding prophylaxis.
  • An ⁇ , ⁇ -unsaturated ketone is first prepared by an aldol reaction of a suitable aldehyde with a methyl ketone (J. March, Advanced Organic Chemistry, 4 ed., J. Wiley, New York, 1992, pp. 937-944).
  • the double bond and the keto group are hydrogenated. If necessary, only the double bond can be hydrogenated first and then the keto group can be reduced (J. March, Advanced Organic Chemistry, 4 * 1 ed., J. Wiley, New York, 1992, pp. 771-783; 910-920).
  • a suitable aldehyde is reacted in a Grignard reaction with a methyl magnesium halide (J. March, Advanced Organic Chemistry, 4 lh ed., J. Wiley, New York, 1992, pp. 920-931). If double bonds are present, the corresponding saturated compounds can be obtained by catalytic hydrogenation (Scheme 4).
  • Preparations according to the invention in particular cosmetic, oral hygiene and dermatological preparations, comprise an antibacterially effective amount of a compound of the formula I (the information above regarding the substituents and the preferred compounds correspondingly apply), and at least one further ingredient which is suitable for a z.
  • a compound of the formula I the information above regarding the substituents and the preferred compounds correspondingly apply
  • cosmetic, oral hygiene or dermatological preparation is typical.
  • the preparations according to the invention cannot usually be used as a lubricant for the mechanical processing or processing of materials.
  • the preparations according to the invention generally do not contain any corrosion inhibitor (organic boron compounds), no EP active ingredient (sulfur and phosphorus additives), no defoamer, no formaldehyde releaser and no boric acid
  • the compounds of formula I to be used according to the invention can also be used to prevent the spoilage of organic substances and preparations, in particular the spoilage of cosmetic, dermatological and oral hygiene preparations, by infestation with gram-positive bacteria.
  • the formulation is mixed with an antibacterially effective amount of one or more compounds of the formula I, the statements made above regarding the substituents and the compounds of the formula I to be used with preference apply accordingly.
  • the compounds of the formula I are preferably used in a concentration of 0.05-10% by weight, based on the total mass of the substance or formulation.
  • the secondary alcohols of the formula (I) harmonize with a large number of customary cosmetic auxiliaries and additives, above all because the compounds of the formula (I) have no or only a very slight odor. This applies in particular to the formulations which are customary in deodorant or antiperspirant formulations
  • Perfume ingredients The combination of astringents, predominantly aluminum salts such as aluminum hydroxychloride, with the antimicrobial substances according to the invention of the formula (I) in one and the same composition is also advantageous.
  • One or more antimicrobial compounds of the formula (I) can be used in preparations.
  • the total content of secondary alcohols according to the invention is usually in the range from 0.005 to 50% by weight, preferably in the range from 0.01 to 20% by weight. , particularly preferably 0.1 to 5% by weight of the compounds according to the invention, and very particularly preferably 0.5 to 3% by weight, based on the total weight of the preparation.
  • the compounds of formula (I) are preferably used in cosmetic, oral hygiene or dermatological preparations.
  • the compounds according to the invention can be incorporated without difficulty into common cosmetic, oral hygiene or dermatological preparations, advantageously in pump sprays, aerosol sprays, creams, ointments, tinctures, lotions, toothpastes, mouthwashes, tooth gels, nail care products (e.g. nail polishes, nail polish removers, nail balms) and the like -
  • the compounds according to the invention can also be microencapsulated, spray-dried, present as inclusion complexes or as extrusion products and used in this form and incorporated, for example, in formulations.
  • the properties of the active compounds modified in this way can be modified by so-called "coating” with suitable materials a more targeted release can be further optimized, for which purpose wax-like plastics such as, for example, polyvinyl alcohol are preferably used.
  • the microencapsulation of the active compounds can be carried out, for example, by the so-called coacervation process with the aid of capsule materials, for example made of polyurethane-like substances or soft gelatin
  • Spray drying of an emulsion or dispersion containing the active ingredient can be produced, whereby modified starches, proteins, dextrin and vegetable gums can be used as carriers.
  • Inclusion complexes can e.g. by adding dispersions of the active ingredient and cyclodextrins or urea derivatives in a suitable solvent, e.g. Water.
  • Extrusion products can be obtained by fusing the active ingredients with a suitable waxy substance and by extrusion with subsequent solidification, if appropriate in a suitable solvent, e.g. Isopropanol,
  • Preparations according to the invention can contain auxiliaries of the kind normally used in cosmetic or therapeutic preparations, for example preservatives, abrasives, antibacterial agents, anti-inflammatory agents, anti-irritants, anti-irritants, antimicrobials, antioxidants, astringents, antiseptics, antistatic agents, binders, buffers, buffers, buffers, buffers.
  • auxiliaries of the kind normally used in cosmetic or therapeutic preparations, for example preservatives, abrasives, antibacterial agents, anti-inflammatory agents, anti-irritants, anti-irritants, antimicrobials, antioxidants, astringents, antiseptics, antistatic agents, binders, buffers, buffers, buffers, buffers, buffers.
  • Carrier materials chelating agents, cell stimulants, cleaning agents, caring agents, surface-active substances, deodorising agents, plasticizers, bactericides, emulsifiers, enzymes, essential oils, film formers, fixatives, foaming agents, foam stabilizers, substances for preventing foaming, foam boosters, gelling agents , moisturizing agents, moisturizing substances, moisturizing substances, bleaching agents, optically brightening agents, dirt-repellent agents, friction-reducing agents, lubricants, opacifiers, opaque agents, brighteners, polymers, powders, proteins, abrasives,
  • Silicones skin soothing agents, skin cleansing agents, skin care agents, skin healing agents, cooling agents, skin cooling agents, warming agents, skin warming agents, stabilizers, UV absorbing agents, UV filters, suspending agents, thickening agents, vitamins, oils, waxes, fats, Phospholipids, saturated fatty acids, mono- or polyunsaturated fatty acids, ⁇ -hydroxy acids, polyhydroxy fatty acids, plasticizers, dyes, color-protecting agents, pigments, flavors, flavorings, perfumes, fragrances or other common components of such preparations such as alcohols, polyols, electrolytes, organic solvents or Silikonderivate-
  • Fragrances and flavors that can be combined with the secondary alcohols of the formula (I) in cosmetic, oral hygiene or dermatological preparations can be found, for example, in Bauer, Garbe, Surburg, Common Fragrance and Flavor Materials, Wiley-VCH, 4th ed. , 2001 or in S. Arctander, Perfume and Flavor Chemicals, Vol. I and II, Montclair, NJ, 1969, self-published.
  • UV absorbers such as Neo Heiiopane ® contain such protection from sunlight.
  • Suitable light stabilizers are, for example, organic UV absorbers from the class of 4-aminobenzoic acid and derivatives, salicylic acid derivatives, benzophenone derivatives,
  • Dibenzoylmethane derivatives diphenylacrylates, 3-imidazol-4-yl-acrylic acid and their esters, benzofuran derivatives, benzylidene malonate derivatives, polymeric UV absorbers, containing one or more organosilicon residues, cinnamic acid derivatives, camphor derivatives, trianilino -s- triazine derivatives, 2-hydroxyphenylbenzotriazole derivatives, 2-
  • Phenylbenzimidazole-5-sulfonic acid and its salts anthranilic acid menthyl ester, benzotriazole derivatives.
  • UV absorbers which can advantageously be used in preparations according to the invention, is of course not intended to be limiting: 4-aminobenzoic acid, 4-aminobenzoic acid ethyl ester, 4-dimethylaminobenzoic acid 2-ethylhexyl ester, 4-aminobenzoic acid glycerol ester, salicylic acid homo- menthyl esters (homosalates), salicylic acid 2-ethylhexyl ester,
  • Triethanolamine salicylate 4-isopropylbenzyl salicylate
  • the amount of non-particulate UV absorber (one or more compounds) in preparations according to the invention is preferably 0.001 to 30% by weight.
  • the total amount of filter substances is preferably 0.1 to 30% by weight, particularly preferably 0.2 to 10 % By weight, in particular 0.5 to 8% by weight, based on the total weight of the preparation.
  • particulate UV filters or inorganic pigments can be used, which can optionally be hydrophobized, such as the oxides of titanium (TiO 2 ), zinc (ZnO), iron (Fe 2 O 3 ), zirconium (ZrO 2 ), silicon (SiO 2 ), manganese (for example MnO), aluminum (Al 2 O 3 ), cerium (for example Ce 2 O 3 ) and / or mixtures thereof.
  • Antioxidants suitable and / or customary for cosmetic and / or dermatological applications can be used in the preparations according to the invention.
  • the antioxidants are advantageously selected from the group consisting of amino acids (e.g. glycine, histidine, tyrosine, tryptophan) and their derivatives, imidazoles (e.g. urocanic acid) and their derivatives, peptides such as D, L-carnosine, D-carnosine, L-camosine and their derivatives (e.g. anserine), carotenoids, carotenes (e.g. ⁇ -carotene, ß-carotene, lycopene) and their derivatives, lipoic acid and their derivatives (e.g.
  • amino acids e.g. glycine, histidine, tyrosine, tryptophan
  • imidazoles e.g. urocanic acid
  • peptides such as D, L-carnosine, D-carnosine, L-camosine and their derivatives (e.g. anserine)
  • carotenoids e.g
  • thiols e.g. thioredoxin, glutathione, cysteine, cystine , Cystamine and their glycosyl, N-acetyl, methyl, ethyl, propyl, amyl, butyl and lauryl, palmitoyl, oleyl, ⁇ -lininoyl, chole ⁇ teryl and glyceryl esters
  • Diiauryl thiodipropionate distearyl thiodipropionate, thiodipropionic acid and their derivatives (esters, ethers, peptides, lipids, nucleotides, nucleosides and salts) as well as sulfoximine compounds (e.g.
  • buthioninsulfoximines homocysteine sulfoximines, buthioninsulfones, penta-, hexa-, heptoximinin
  • very achieve tolerable dosages e.g. pmol to ⁇ mol / kg
  • metal chelators e.g. ⁇ -hydroxy fatty acids, palmitic acid, phytic acid, lactoferrin), ⁇ -hydroxy acids (e.g. citric acid, lactic acid, malic acid), humic acid, bile acid, bile extracts , Bilirubin, biliverdin, EDTA, EGTA and their derivatives, unsaturated fatty acids and their derivatives (e.g. ⁇ -linolenic acid, linoleic acid, oleic acid), folic acid and their derivatives, ubiquinone and ubiquiole and their derivatives, vitamin C and derivatives (e.g.
  • Ascorbyl palmitate Mg-Ascor byl phosphate, ascorbyl acetate), tocopherols and derivatives (e.g. vitamin E acetate), vitamin A and derivatives (vitamin A palmitate) as well as konyferyl benzoate of benzoin, rutinic acid and its derivatives, ferulic acid and its derivatives, butylated hydroxytoluene, Bu- tylhydroxyanisole, nordihydroguajakh resinic acid, nordihydroguajaretic acid, trihydroxybutyrophenone, uric acid and its derivatives, mannose and its derivatives, zinc and its derivatives (e.g.
  • ZnO, ZnS0 4 selenium and its derivatives (e.g. selenomethionine), stilbenes and their derivatives (e.g. stilbene oxide), transbenzene and the derivatives suitable according to the invention (salts, esters, ethers, sugars, nucleotides, nucleosides, peptides and lipids) of these active substances mentioned.
  • selenomethionine e.g. stilbene oxide
  • transbenzene and the derivatives suitable according to the invention salts, esters, ethers, sugars, nucleotides, nucleosides, peptides and lipids
  • the amount of the antioxidants (one or more compounds) in preparations according to the invention is preferably 0.001 to 30% by weight, particularly preferably 0.05 to 20% by weight, in particular 1 to 10% by weight, based on the total weight of the preparation ,
  • vitamin E and / or its derivatives represent the antioxidant (s)
  • vitamin A or vitamin A derivatives or carotenes or their derivatives represent the antioxidant or antioxidants, it is advantageous for their respective concentration to be in the range from 0.001 to 10% by weight, based on the total weight of the preparation , to choose.
  • surface-active substances which can advantageously be used in preparations according to the invention are conventional soaps, for example fatty acid salts of sodium, alkyl sulfates, alkyl ether sulfates, alkane and alkylbenzenesulfonates, sulfoacetates, sulfobetaines, sarcosinates, amidosulfobetaines, sulfosuccinates, sulfosuccinic acid
  • alkyl ether carboxylates protein-fatty acid condensates, alkyl betaines and amidobetaines, fatty acid alkanolamides, polyglycol ether derivatives.
  • the surface-active substance can be present in a concentration between 1% by weight and 50% by weight in the shampooing agent, or in the washing, showering or bathing preparation.
  • Cosmetic and dermatological preparations according to the invention can be in various forms, such as those e.g. are usually used for this type of preparation. So you can e.g. a solution, an emulsion of the type water-in-oil (W / O) or of the type oil-in-water (O / W), or a multiple emulsion, for example of the type water-in-oil-in-water (W / O / W), a gel, a hydro-dispersion, a solid stick or an aerosol
  • the cosmetic or dermatological preparation according to the invention is a solution or lotion
  • the following can be used as solvents: water or aqueous solutions; Oils, such as triglycerides of capric or caprylic acid, but preferably castor oil; - Fats, waxes and other natural and synthetic fat bodies, preferably esters of fatty acids with alcohols with a low C number, for example with isoprapanol, propylene glycol or glycerol, or esters of fatty alcohols with alkanoic acids with a low C number or with fatty acids; Alcohols, diols or polyols of low C number, and their ethers, preferably ethanol, isoprapanol, propylene glycol, glycerol, ethylene glycol, ethylene glycol monoethyl or monobutyl ether,
  • Water can also be a component of alcoholic solvents.
  • Preparations according to the invention are often preferably emulsions and contain e.g. the fats, oils, waxes and other fat bodies mentioned, and also water and an emulsifier, as is usually used for such a type of formulation.
  • Preparations according to the invention can be present as gels and then usually contain alcohols of low C number, e.g. Ethanol, isoprapanol, 1,2-propanediol, glycerol and water or an oil mentioned above in the presence of a thickener which is preferably silicon dioxide or an aluminum silicate in the case of oily-alcoholic gels, and is preferably a polyacrylate in the case of aqueous-alcoholic or alcoholic gels.
  • alcohols of low C number e.g. Ethanol, isoprapanol, 1,2-propanediol, glycerol and water or an oil mentioned above in the presence of a thickener which is preferably silicon dioxide or an aluminum silicate in the case of oily-alcoholic gels, and is preferably a polyacrylate in the case of aqueous-alcoholic or alcoholic gels.
  • Cosmetic and dermatological preparations according to the invention can be present as gels which, in addition to at least one compound according to the invention and solvents usually used therefor, also include organic thickening agents, for example gum arabic, xanthan gum, sodium alginate, cellulose derivatives, preferably methyl cellulose, hydroxymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropyl methyl cellulose or inorganic Thickeners, for example aluminum silicates such as bentonites, or a mixture of polyethylene glycol and polyethylene glycol stearate or distearate, are contained.
  • the thickener is in the gel, for example, in an amount between 0.1 and 30% by weight, preferably between 0.5 and 15 % By weight.
  • Preparations according to the invention may be in the form of solid sticks and then contain e.g. natural or synthetic waxes, fatty alcohols or fatty acid esters. Lip care sticks and deodorant sticks (“deodorant sticks”) are preferred.
  • Suitable blowing agents for cosmetic or dermatological preparations according to the invention which can be sprayed from aerosol containers are the customary known volatile, liquefied blowing agents, e.g. Hydrocarbons (propane, butane, isobutane) are suitable, which can be used alone or in a mixture with one another. Compressed air can also be used advantageously.
  • Hydrocarbons propane, butane, isobutane
  • a pH range of 3.5 - 7.5 is advantageous. It is particularly favorable to choose the pH in a range from 4.0 to 6.5.
  • the cosmetic, oral hygiene and / or dermatological preparations according to the invention can be used to treat the skin, hair, teeth and oral mucosa in the sense of dermatological treatment or treatment in the sense of nourishing cosmetics. But they can also be used in make-up products in decorative cosmetics or in oral hygiene.
  • the cosmetic, oral hygiene and / or dermatological formulations according to the invention are applied in a sufficient amount to the skin, teeth, gums and oral mucosa and tongue and / or hair in the manner customary for cosmetics and dermatics.
  • Oral hygiene products in the present invention include the formulations familiar to the person skilled in the art for cleaning and maintaining the oral cavity and the
  • Throat cavity and breath freshening understood are creams, gels, pastes, foams, emulsions, suspensions, areosols, sprays as well as capsules, granules, lozenges, tablets, candies or chewing gums, without this list Dosage forms are limiting with regard to the possible uses. Such formulations serve to clean and care for tooth substance and oral cavity and to refresh the breath. If the secondary alcohols 10 of the formula (I) to be used according to the invention are incorporated into deodorants, these deodorants can be, for example, liquid as an aerosol spray, pump spray, gel, roll-on and the like or as a solid preparation, for example as a stick or powder available.
  • Cosmetic and / or dermal tological preparations which are in the form of a sunscreen are also advantageous. These advantageously additionally contain at least one UVA filter and / or at least one UVB filter and / or at least one inorganic pigment.
  • Preparations according to the invention for treating the hair are, for example, shampooing agents, preparations which are used when the hair is rinsed or after the shampooing, before or after the permanent wave treatment, before or after the coloring or decolorization of the hair, for preparations for blow-drying or inlaying the hair, preparations for coloring or decoloring, for a hairdressing and treatment lotion, a hair lacquer or around permanent wave products.
  • the preparations are anti-dandruff agents, such as anti-dandruff shampoos.
  • Cosmetic preparations according to the invention which are a shampooing agent or a washing, showering or bathing preparation preferably contain at least one anionic, nonionic or amphoteric surface-active substance or mixtures thereof.
  • This cosmetic or dermatological preparation can also be an aerosol with the auxiliaries usually used for it.
  • a cosmetic preparation according to the invention in the form of a lotion that is not rinsed out, in particular a lotion for inlaying the hair, a lotion that is used for blow-drying the hair, a styling and treatment lotion is generally an aqueous, alcoholic or aqueous-alcoholic Solution and contains at least one cationic, anionic, non-ionic or amphoteric polymer or mixtures thereof.
  • Cosmetic and dermatological preparations according to the invention for the treatment and care of the hair can be present as emulsions which are of the non-ionic or anionic type.
  • non-ionic emulsions contain oils or fatty alcohols, which can be polyethoxylated or polypropoxylated, for example, or also mixtures of the two organic components. This emulmuls
  • Sions may contain cationic surface-active substances.
  • Anionic emulsions are preferably of the soap type and contain at least one ethoxylated or propoxylated organic compound according to the invention with an anionic or non-ionic character.
  • Odor Odorless i) 4- (2,4-Dimethylphenyi) -3-methyl-2-butanol from 2,4-
  • Odor almost odorless, uncharacteristic j) 4- (2,4-dimethylphenyl) -2-butanol from 2,4-dimethylbenzaldehyde
  • the minimum inhibitory concentration (MIC) of the claimed substances was determined in the serial dilution test (H. Brandis, G. Pulverer: Textbook of Medical Microbiology. 6th revised edition, Gustav Fischer Verlag Stuttgart, 1988; page 200ff.) against various cosmetically relevant germs.
  • the test was transferred to the microtiter plate format and the MIC value was used to determine the concentration at which no significant increase in turbidity compared to the controls was observed after 16 hours of incubation at the wavelength of 620 nm.
  • the test is based on the work of Goldberg and Rosenberg (Production of Oral Malodor in an in vitro System, S. Goldberg and. Rosenberg, pp.143 - 150, in: Bad Breath- A multidisciplinary Approach, Eds: D. van Steenberghe, M. Rosenberg, Leuven University Press, 1996) and was adapted for better reproducibility.
  • a sterile liquid medium which is inoculated with fresh morning saliva, is incubated for a few days in a Coy box at 37 "C and then smelled by an inspector panel.
  • Triclosan ® was added in a concentration of 0.05%.
  • the inoculated tubes had the same smell after incubation as the non-inoculated tubes.
  • the minimum active concentration (MWK) will silt up in the present case, at which the formation of bad breath is inhibited.
  • Glycerol monostearate 1.50 1.50 1.50
  • Carbopol 980 (neutralized) 0.30 0.30 0.30 0.30
  • Paraffin oil ad 100.00 ad 100.00 ad 100.00
  • Paraffin oil ad 100.00 ad 100.00 ad 100.00
  • Paraffin oil ad 100.00 ad 100.00 ad 100.00
  • Citric acid 0.30 0.30 0.30 Citric acid 0.30 0.30 0.30
  • the liquid phase obtained by mixing the respective components together is filled into an aerosol container together with a propane-butane mixture (2: 7) in a ratio of 39:61.
  • Sorbitol 70% 29.00 29.00 29.00
  • Titanium dioxide 1.00 1.00 1.00
  • Sorbitol powder 38.00 37.00 35.50
  • Emulsifier / emulsifier 0.30 0.30 0.30 0.30
  • part A all substances except the zinc oxide were heated to 85 ° C. and the zinc oxide was carefully dispersed in the mixture.
  • the components of Part B were mixed, heated to 85 ° C and added to Part A with stirring.
  • Part C was added to the mixture of parts A and B and the mixture was then homogenized using a dispersing tool.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dentistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Disclosed is the use of a compound of formula (I) as an agent against gram-positive bacteria, wherein m and n independently represent 0 and 1, R1 to R6 independently represent hydrogen or methyl, and A represents a phenyl group that is optionally substituted with additional C1 to C5 alkyl substituents, a norborane-2-yl group, or a pinane-3-yl group.

Description

Sekundäre Alkohole als antimikrobielle Wirkstoffe Secondary alcohols as antimicrobial agents
Die vorliegende Erfindung betrifft die Verwendung bestimmter sekundärer Alkohole als Wirkstoffe gegen Gram-positive Bakterien, wie sie insbesondere ursächlich sind für (a) Körpergeruch, (b) unreine Haut und/oder Akne sowie (c) Mundgeruch und/oder schlechten Atem. Einige der erfindungsgemaß einsetzbaren Verbindungen sind dabei neu, ebenso wie die Zubereitungen, in denen sie eingesetzt werden-The present invention relates to the use of certain secondary alcohols as active ingredients against Gram-positive bacteria, as are particularly responsible for (a) body odor, (b) impure skin and / or acne, and (c) bad breath and / or bad breath. Some of the compounds that can be used according to the invention are new, as are the preparations in which they are used.
Der gesunde warmblütige Organismus, insbesondere die gesunde menschliche Haut und Schleimhaut, ist mit einer Vielzahl nicht pathoge- ner Mikroorganismen besiedelt. Diese sogenannte Mikroflora der Haut bzw. Schleimhaut ist nicht nur unschädlich, sie stellt einen wichtigen Schutz zur Abwehr opportunistischer oder pathogener Keime dar. Andere Mikroorganismen können dagegen den Zustand der gesunden The healthy warm-blooded organism, especially the healthy human skin and mucous membrane, is populated with a large number of non-pathogenic microorganisms. This so-called microflora of the skin or mucous membrane is not only harmless, it represents an important protection for the defense against opportunistic or pathogenic germs. In contrast, other microorganisms can improve the condition of the healthy ones
Haut und Schleimhaut, z.B. auch ihren Geruch, maßgeblich beeinflussen.Skin and mucous membrane, e.g. also significantly influence their smell.
Es besteht ein ständiger Bedarf an Substanzen und Mitteln mit antimikrobiellen Eigenschaften. Insbesondere werden dabei antimikrobielle Wirkstoffe gesucht, deren antibakterieiies Spektrum (Antibiogramm) Gram-positive Bakterien umfasst. Es ist bereits bekannt, dass bestimmte Alkohole antimikrobiell wirksam sind. In der Praxis eingesetzt werden bislang vor Allem primäre Alkohole wie z. B. Famesol, ein primärer Sesquiterpenalkohol. Farnesol und andere primäre Alkohole mit antimikrobiellen Eigenschaften besitzen jedoch ein sensibiiisierendes und allergenisierendes Potential, so dass ihr Einsatz in zunehmenden Maße nicht mehr toleriert wird.There is a constant need for substances and agents with antimicrobial properties. In particular, antimicrobial agents are sought, the antibacterial spectrum (antibiogram) of which includes Gram-positive bacteria. It is already known that certain alcohols have an antimicrobial effect. In practice, primary alcohols such as. B. Famesol, a primary sesquiterpene alcohol. However, farnesol and other primary alcohols with antimicrobial properties have a sensitizing and allergenic potential, so that their use is increasingly no longer tolerated.
Es war deshalb die primäre Aufgabe der vorliegenden Erfindung, Verbindungen anzugeben, welche gegen Gram-positive Bakterien wirksam sind. Darüber hinaus sollten die anzugebenden Verbindungen einen allenfalls geringen Eigengeruch besitzen, leicht in antibakterielle Zubereitungen einzuarbeiten sein, in den üblichen kosmetischen Formulierungen ebenso wie unter den erforderlichen anwendungstechnischen Bedingungen stabil sein, gut zugänglich sein, d. h. durch einfache chemische Reaktionen herstellbar sein, sowie gut verträglich sein, d. h. bei ihrer Anwendung keine unvertretbare Beeinträchtigung der Gesundheit bewirken-It was therefore the primary object of the present invention to provide compounds which are active against Gram-positive bacteria. In addition, the compounds to be specified should have a possibly slight intrinsic odor, be easy to incorporate into antibacterial preparations, be stable in the usual cosmetic formulations and also under the required application conditions, and be readily accessible, ie. H. be producible by simple chemical reactions and be well tolerated, d. H. do not cause unacceptable health effects when used-
Die vorgenannte Aufgabe wird gelöst durch die Verwendung einer Verbindung der Formel IThe aforementioned object is achieved by using a compound of the formula I.
Figure imgf000003_0001
Figure imgf000003_0001
als Wirkstoff gegen Gram-positive Bakterien worin m und n unabhängig voneinander 0 und 1 bedeuten,as an active ingredient against Gram-positive bacteria in which m and n are independently 0 and 1,
R1 bis R6 unabhängig voneinander Wasserstoff oder Methyl bedeuten undR 1 to R 6 are independently hydrogen or methyl and
A eine Phenylgruppe, die gegebenenfalls mit weiteren C,- bis C5- Alkylsubstituenten substituiert ist, eine Norbornan-2-yl- oder eine Pinaπ- 3-yl-Grυppe ist.A is a phenyl group optionally substituted with a further C, - to C 5 - substituted alkyl substituents, a norbornane-2-yl or a Pinaπ- 3-yl-Grυppe.
Vorzugsweise ist mindestens eine in der erfindungsgemäß einzusetzenden Verbindung der Formel I vorhandene Gruppe R1 bis R6 Methyl (d. h. falls m = n = 0 einer der Substituenten R1 oder R2; falls m = 0 und n = 1 einer der Substituenten R1, R2, R3 und R4 ; falls m = 1 und n = 0 einer der Substituenten R1, R2, R5 und R6), falls A eine Phenylgruppe oder eine monoalkylsubstituierte Phenylgruppe ist.Preferably at least one group R 1 to R 6 present in the compound of formula I to be used according to the invention is methyl (ie if m = n = 0 one of the substituents R 1 or R 2 ; if m = 0 and n = 1 one of the substituents R 1 , R 2 , R 3 and R 4 ; if m = 1 and n = 0 one of the substituents R 1 , R 2 , R 5 and R 6 ), if A is a phenyl group or a monoalkyl-substituted phenyl group.
Bei den erfindungsgemäß einzusetzenden Alkoholen handelt es sich um sekundäre Alkohole, die einen Arylrest (Gruppe A) umfassen- Die Einsetzbarkeit der Verbindungen der Formel I zur Bekämpfung Grampositiver Bakterien ergab sich nicht aus dem Stand der Technik.The alcohols to be used according to the invention are secondary alcohols which comprise an aryl radical (group A). The use of the compounds of the formula I for combating gram-positive bacteria did not result from the prior art.
J. Agric- Food Chem- 1993 (41), 2447-2450 (Kubo et al.) offenbart zwar, dass bestimmte sekundäre Alkohole wie 2-Undecanol und Geranylacetol gegen Streptococcus mutans (ein Gram-positives Bakterium) wirksam sind, und in einer jüngeren Veröffentlichung in Bioorg. Med. Chem. 1995 (3), 873 - 880 (Kubo et al.) werden ergänzend Angaben zur antimikrobiellen Wirksamkeit sekundärer Alkohole gegen eine Reihe Gram-positiver Bakterien offenbart, doch es findet sich kein Hinweis auf die Einsetzbarkeit von sekundären Alkoholen, die unter die Formel I fallen. J. Agric-Food Chem-1993 (41), 2447-2450 (Kubo et al.) Discloses that certain secondary alcohols such as 2-undecanol and geranylacetol are effective against Streptococcus mutans (a gram-positive bacterium), and in one recent publication in Bioorg. Med. Chem. 1995 (3), 873-880 (Kubo et al.) Supplementary information on the antimicrobial activity of secondary alcohols against a number of Gram-positive bacteria is disclosed, but there is no indication of the applicability of secondary alcohols which are listed under the formula I fall.
WO 01/85120 A1 betrifft zwar die Verwendung des sekundären Alkohols 6,10-DimethyI-5,9-undecadien-2-ol als antimikrobieller Wirkstoff, gibt aber ebenfalls keinen Hinweis auf die Einsetzbarkeit von sekundären Alkoholen, welche unter die Formel l fallen.Although WO 01/85120 A1 relates to the use of the secondary alcohol 6,10-dimethyI-5,9-undecadien-2-ol as an antimicrobial active ingredient, it also gives no indication of the usability of secondary alcohols which come under the formula I.
DE 100 25 124 A1 beschreibt Wirkstoffkombinationen, die einen Glycerinmonoalkylether sowie einen Aryl-substiuierten Alkohol umfassen. Es ist dabei nicht ausgeschlossen, dass der Glycerinmonoalkylether mit einem sekundären Aryl-substituierten Alkohol kombiniert wird, besonders bevorzugt sind jedoch die primären Alkohole Phenoxyethanoi, Anisalkohol und 2-Methyl-5-phenyl-pentan-1- ol sowie der tertiäre Alkohol Phenyl-dimethylethylcarbonol. Nicht offenbart wird, dass Aryl-substituierte Alkohole alleine eine Wirkung gegen Gram-positive Bakterien entfalten können, und dies gilt insbesondere für Aryl-substituierte sekundäre Alkohole.DE 100 25 124 A1 describes combinations of active ingredients which comprise a glycerol monoalkyl ether and an aryl-substituted alcohol. It is not excluded that the glycerol monoalkyl ether is combined with a secondary aryl-substituted alcohol, but the primary alcohols phenoxyethanoi, anise alcohol and 2-methyl-5-phenyl-pentan-1-ol and the tertiary alcohol phenyl-dimethylethylcarbonol are particularly preferred , It is not disclosed that aryl-substituted alcohols alone can have an effect against Gram-positive bacteria, and this applies in particular to aryl-substituted secondary alcohols.
Die US 4,006,218 (Sipos) offenbart die Verwendung bestimmter Phenylalkanole, unter denen sich auch sekundäre Alkohole befinden, als Verstärker (potentiator) der antimikrobiellen Wirkung eines antimikrobiellen Agents. Es wird kein Hinweis gegeben auf eine eigene antimikrobielle Wirksamkeit der zum Zwecke der Verstärkung eingesetzten Phenylalkanole.US 4,006,218 (Sipos) discloses the use of certain phenylalkanols, including secondary alcohols, as enhancers (potentiators) of the antimicrobial activity of an antimicrobial agent. There is no indication of the antimicrobial activity of the phenylalkanols used for the purpose of reinforcement.
Die EP 0 919 607 A2 offenbart Additive zur physikalischen und/oder mikrobiologischen Stabilisierung der flüssigen oder viskosen Zusammensetzung eines Schmierstoffs, wobei das Additiv ein aromatischer Alkohol ist, der auch sekundär sein kann. Nicht offenbart wird jedoch, gegen welche Keime das Additiv wirksam sein soll; ganz allgemein angegeben wird allerdings, dassEP 0 919 607 A2 discloses additives for the physical and / or microbiological stabilization of the liquid or viscous composition of a lubricant, the additive being an aromatic alcohol, which can also be secondary. However, it is not disclosed which germs the additive should be effective against; however, it is generally stated that
Kühlschmierstoflzusammensetzungen mikrobiologisch stabilisiert werden- Da nun aber Kühlschmierstoffe üblicherweise nur von Bakterien besiedelt werden, die Gram-negativ sind, ergibt sich aus der EP 0 919 607 A2 zumindest kein Hinweis darauf, dass die als Additiv zur Cooling lubricant compositions are microbiologically stabilized. However, since cooling lubricants are usually only colonized by bacteria that are Gram-negative, EP 0 919 607 A2 at least gives no indication that they are used as an additive
Stabihsierung von Kuhlschmierstoffen einsetzbaren aromatischen Alkohole eine antibakteπeile Wirkung gegen Gram-positive Bakterien besitzenStabilization of aromatic lubricants usable in cooling lubricants have an antibacterial effect against Gram-positive bacteria
Schließlich sei noch auf die DE 4 447 361 A1 hingewiesen, welche die Verwendung primärer Arylalkylalkohole als antimikrobielle Wirkstoffe offenbartFinally, reference is made to DE 4 447 361 A1, which discloses the use of primary arylalkyl alcohols as antimicrobial active ingredients
Wie sich bereits aus der vorstehenden Würdigung verschiedener Veröffentlichungen ergibt, wurden in den letzten Jahrzehnten zahlreiche Untersuchungen zur antimikrobiellen Wirksamkeit von Alkoholen durchgeführt Es ist deshalb äußerst überraschend, dass bislang noch nicht erkannt wurde, dass die erfindungsgemaß einzusetzenden Verbindungen der Formel I eine ganz hervorragende Wirksamkeit gegenüber Gram-positiven Bakteπen besitzen Für den Einsatz in der Praxis sind die Verbindungen der Formel I dabei besonders geeignet, weil sie allenfalls einen geringen Eigengeruch besitzen und durch einfache chemische Reaktionen herstellbar sind Die sekundären Alkohole der Formel I sind als Wirkstoffe gegen Gram-positive Bakterien insbesondere in kosmetischen, mundhygienischen und/oder dermatologischen Zubereitungen einsefzbarAs can already be seen from the above assessment of various publications, numerous studies on the antimicrobial activity of alcohols have been carried out in the past decades. It is therefore extremely surprising that it has not hitherto been recognized that the compounds of the formula I to be used according to the invention have a very excellent activity against Having Gram-positive bacteria For use in practice, the compounds of the formula I are particularly suitable because they have at most a low intrinsic odor and can be prepared by simple chemical reactions. The secondary alcohols of the formula I are active substances against Gram-positive bacteria in particular can be used in cosmetic, oral hygiene and / or dermatological preparations
Wenngleich die vorliegende Erfindung ganz allgemein die Verwendung einer Verbindung der Formel IAlthough the present invention generally uses a compound of formula I
Figure imgf000006_0001
mit den eingangs genannten Bedeutungen der Substituenten als
Figure imgf000006_0001
with the meanings of the substituents mentioned as
Wirkstoff gegen Gram-positive Bakterien betπfft, ist es doch besonders bevorzugt, die Verbindung der Formel I gegen Gram-positive Bakterien Active ingredient against Gram-positive bacteria, it is particularly preferred, the compound of formula I against Gram-positive bacteria
einzusetzen, die aus der Gruppe ausgewählt sind, die aus (a) Körpergeruch verursachenden, (b) unreine Haut und/oder Akne verursachenden und (c) Mundgeruch und/oder schlechten Atem verursachenden Bakterien besteht. Dem Fachmann sind die Gram-positiven Bakterien bekannt, welche für die unangenehmen Körperzustände gemäß (a) - (c) verantwortlich sind.to be used, which are selected from the group consisting of (a) body odor, (b) impure skin and / or acne and (c) bad breath and / or bad breath causing bacteria. Gram-positive bacteria are known to the person skilled in the art, which are responsible for the unpleasant body conditions according to (a) - (c).
Gram-positive Bakterien, die Körpergeruch verursachen, sind Bakterien z. B. aus den Gattungen Corynebacterium, Staphyiococcus, Micrococcus und Brevibacterium, insbesondere Corynebacterium xerosis, Staphyiococcus epidermidis und Staphyiococcus hominis, Micrococcus luteus und/oder Micrococcus sedentarius und Brevibacterium epidermidis.Gram-positive bacteria that cause body odor are bacteria e.g. B. from the genera Corynebacterium, Staphyiococcus, Micrococcus and Brevibacterium, in particular Corynebacterium xerosis, Staphyiococcus epidermidis and Staphyiococcus hominis, Micrococcus luteus and / or Micrococcus sedentarius and Brevibacterium epidermidis.
Gram-positive Bakterien, die unreine Haut und/oder Akne verusacheπ, sind beispielsweise Bakterien der Gattung Propionibacterium, insbesondere Propionibacterium acnes.Gram-positive bacteria that verusacheπ impure skin and / or acne are, for example, bacteria of the genus Propionibacterium, in particular Propionibacterium acnes.
Gram-positive Bakterien, die Mundgeruch und/oder schlechten Atem verursachen, sind beispielsweise Bakterien der Gattungen Actinomyces, Eubacterium, Rothia und Stomatococcus, insbesondere Actinomyces viscosus, Eubacterium brachy, Eubacterium nodatum, Eubacterium saburreum, Eubacterium timidum und Eubacterium yurrii, sowie Rothia denticariosus und Stomatococcus mucilaginosus.Gram-positive bacteria that cause bad breath and / or bad breath are, for example, bacteria of the genera Actinomyces, Eubacterium, Rothia and Stomatococcus, in particular Actinomyces viscosus, Eubacterium brachy, Eubacterium nodatum, Eubacterium saburreum, Eubacterium timidum and Eubacterium denticus and Roth Stomatococcus mucilaginosus.
Die sekundären Alkohole der Formel (!) harmonieren mit einer Vielzahl üblicher kosmetischer Hilfs- und Zusatzstoffe. Die Verbindungen der Formel I können deshalb in die verschiedensten Darreichungsformen und Zubereitungen eingearbeitet werden. Auf die Haut zu appiizierende Zubereitungen, die Verbindungen der Formel I enthalten, sind in der Lage, die Zahl der Gram-positiven Bakterien, die für das jeweilige Phänomen bzw. die jeweilige Beeinträchtigung gemäß obiger The secondary alcohols of formula (!) Harmonize with a variety of common cosmetic auxiliaries and additives. The compounds of formula I can therefore be incorporated into a wide variety of dosage forms and preparations. Preparations to be applied to the skin which contain compounds of the formula I are able to determine the number of Gram-positive bacteria responsible for the respective phenomenon or the particular impairment according to the above
Aufeählung (a) bis (c) verantwortlich sind, zu reduzieren, wobei die Mikroflora der kontaktierten Haut geschont wird. Zubereitungen, welche die Verbindungen der Formel I enthalten, zeichnen sich regelmäßig durch eine gute Hautverträglichkeit aus, sofern keiner der sonstigen in der Zubereitung enthaltenen Bestandteile eine Unverträglichkeit verursacht-Enumeration (a) to (c) are responsible for reducing, while the microflora of the contacted skin is protected. Preparations which contain the compounds of the formula I are regularly distinguished by good skin tolerance, provided that none of the other constituents contained in the preparation cause an intolerance.
Die vorstehenden Bemerkungen gelten insbesondere für Desodorantien, speziell solche gegen Körpergeruch und Mundgeruch, welche die sekundären Alkohole der Formel I enthalten- Derartige Desodorantien besitzen eine gute Hautverträglichkeit (inklusiveThe above remarks apply in particular to deodorants, especially those against body odor and bad breath, which contain the secondary alcohols of the formula I. Such deodorants have good skin tolerance (including
Schleimhautverträglichkeit) und zeigen - eine ausreichende Dosierung der erfindungsgemäß einzusetzenden Verbindung der Formel I vorausgesetzt - eine Wirksamkeit über einen längeren Zeitraum, und zwar in der Größenordnung von mindestens einem halben Tag, ohne dass ihre Wirkung spürbar nachlässt.Tolerance to the mucous membrane) and - provided a sufficient dosage of the compound of the formula I to be used according to the invention - have an activity over a longer period of time, of the order of magnitude of at least half a day, without their action noticeably diminishing.
Unter den Verbindungen der Formel I sind diejenigen bevorzugt, für die gilt: m + n = 0 oder 2. Diese Verbindungen besitzen eine besonders hohe Wirkung gegenüber Gram-positiven Bakterien.Preferred among the compounds of the formula I are those for which: m + n = 0 or 2. These compounds have a particularly high activity against Gram-positive bacteria.
Weiter bevorzugt sind Verbindungen der Formel I, die zumindest drei, vorzugsweise zumindest vier CH3-Gruppen besitzen, denn auch diese sind regelmäßig besonders wirksam gegenüber Gram-positiven Bakterien.Compounds of the formula I which have at least three, preferably at least four, CH 3 groups are further preferred, since these too are regularly particularly active against Gram-positive bacteria.
Vorzugsweise ist in den erfindungsgemäß einzusetzenden Verbindungen der Formel I die Gruppe A Phenyl, 2-Methylphenyl, 3- Methylphenyl, 4-Methylphenyl, 4-lsopropylphenyl, 4-tert-ButyIphenyl, 4- Isobutylphenyl, 2,4-Dimethylphenyl, 3,4-Dimethyiphenyl, 2,5- Dimethylphenyl, 2,4,5-Trimethylphenyl, 2,4,6-Trimethylphenyl,In the compounds of formula I to be used according to the invention, group A is preferably phenyl, 2-methylphenyl, 3-methylphenyl, 4-methylphenyl, 4-isopropylphenyl, 4-tert-butylphenyl, 4-isobutylphenyl, 2,4-dimethylphenyl, 3,4 -Dimethyiphenyl, 2,5-dimethylphenyl, 2,4,5-trimethylphenyl, 2,4,6-trimethylphenyl,
Norbornan-2-yI oder Pinan-3-yl, wobei wiederum vorzugsweise Norbornan-2-yI or Pinan-3-yl, again preferably
mindestens eine der Gruppen R1 bis Rβ Methyl ist, falls A Phenyl oder ein monoalkylsubstiuiertes Phenyl ist. Besonders bevorzugt als Wirkstoffe gegen Gram-positive Bakterien sind die folgenden Verbindungen der Formel I:at least one of the groups R 1 to R β is methyl if A is phenyl or a monoalkyl-substituted phenyl. The following compounds of the formula I are particularly preferred as active substances against Gram-positive bacteria:
Figure imgf000009_0001
Figure imgf000009_0002
Figure imgf000009_0001
Figure imgf000009_0002
Figure imgf000010_0001
Figure imgf000010_0002
Figure imgf000010_0001
Figure imgf000010_0002
Unter diesen besonders bevorzugten Verbindungen sind 4-(2,4,5- Trimethylphenyl)-2-butanol (Verbindung 14), 3-Methyl-4-(2,4,5- trimethylphenyI)-2-butanol (Verbindung 4), 4-(4-lsopropylphenyl)-3- methyl-2-butanol (Verbindung 11), 4-(4-lsobutylphenyl)-3-methyl-2- butanol (Verbindung 6), 3-Methyl-4-(2,4,6-trimethyIphenyl)-2-butanol Among these particularly preferred compounds are 4- (2,4,5-trimethylphenyl) -2-butanol (compound 14), 3-methyl-4- (2,4,5-trimethylphenyl) -2-butanol (compound 4), 4- (4-isopropylphenyl) -3-methyl-2-butanol (Compound 11), 4- (4-isobutylphenyl) -3-methyl-2-butanol (Compound 6), 3-methyl-4- (2,4 , 6-trimethyIphenyl) -2-butanol
(Verbindung 8), 4-(3,4-Dimethylphenyl)-3-methyl-2-butanol (Verbindung 17), 4-(3,4-Dimethylphenyl)-2-butanol (Verbindung 18), 4-(2,4- Dimethylphenyl)-3-methyl-2-butanol (Verbindung 12), 4-(2,4- Dimethylphenyl)-2-butanol (Verbindung 13), neu. Die genannten antimikrobiellen Eigenschaften der erfindungsgemäß einzusetzenden sekundären Alkohole der Formel (I) beziehen sich dabei auf alle diastereomeren und, soweit zutreffend, enantiomeren Formen sowie beliebige Mischungen davon.(Compound 8), 4- (3,4-dimethylphenyl) -3-methyl-2-butanol (Compound 17), 4- (3,4-dimethylphenyl) -2-butanol (Compound 18), 4- (2, 4- dimethylphenyl) -3-methyl-2-butanol (compound 12), 4- (2,4-dimethylphenyl) -2-butanol (compound 13), new. The mentioned antimicrobial properties of the secondary alcohols of the formula (I) to be used according to the invention relate to all diastereomeric and, if applicable, enantiomeric forms and any mixtures thereof.
Die Erfindung betrifft auch Verfahren zur Bekämpfung Gram-positiver Bakterien, wobei die Bakterien mit einer antimikrobiell wirksamen Menge einer Verbindung der Formel I oder einer Mischung von zumindest zwei unterschiedlichen Verbindungen der Formel I kontaktiert werden- Für die Verbindungen der Formel I gelten dabei die eingangs genannten Bedeutungen der Substituenten, wobei natürlich auch die Angaben zu den besonders bevorzugten Verbindungen der Formel I weiterhin zutreffen.The invention also relates to methods for controlling Gram-positive bacteria, the bacteria being contacted with an antimicrobially effective amount of a compound of the formula I or a mixture of at least two different compounds of the formula I. The compounds of the formula I mentioned above apply here Meanings of the substituents, the information relating to the particularly preferred compounds of the formula I of course also continuing to apply.
Gemäß einem verwandten Aspekt betrifft die Erfindung auch ein Verfahren zur Bekämpfung von (a) durch Gram-positive Bakterien verursachtem Körpergeruch (b) durch Gram-positive Bakterien verursachte unreiner Haut und/oder Akne und/oder (c) durch Grampositive Bakterien verursachtem Mundgeruch und/oder schlechtem Atem, wobei die Gram-positiven Bakterien mit einer antimikrobiell wirksamen Menge einer Verbindung der Formel I oder einer Mischung von zumindest zwei unterschiedlichen Verbindungen der Formel I kontaktiert werden- Auch insoweit gelten die bereits eingangs genannten Bedeutungen der Substituenten und die Ausführungen zu den bevorzugten Verbindungen der Formel I.According to a related aspect, the invention also relates to a method for controlling (a) body odor caused by Gram-positive bacteria (b) impure skin and / or acne caused by Gram-positive bacteria and / or (c) bad breath caused by Gram-positive bacteria and / or bad breath, the Gram-positive bacteria being contacted with an antimicrobially effective amount of a compound of the formula I or a mixture of at least two different compounds of the formula I. The meanings of the substituents already mentioned at the outset and the explanations for those also apply preferred compounds of formula I.
Zum Zwecke der Kontaktierung wird die Verbindung der Formel I üblicherweise flächig auf den Bereich der Haut (inklusive Schleimhaut) For the purpose of contacting, the compound of the formula I is usually applied flat to the area of the skin (including the mucous membrane)
des menschlichen und tierischen Körpers appliziert, der von den zu bekämpfenden Gram-positiven Bakterien befallen ist. Die Form der Applikation hängt dabei entscheidend von der Darreichungsform der einzusetzenden Verbindung der Formel I ab (siehe dazu unten). Wenngleich das erfindungsgemäße Verfahren in der Regel kosmetischen Zwecken dienen wird, ist auch in manchen Fällen ein therapeutischer Zweck vorhanden. Der Begriff „Bekämpfung" umfasst dabei sowohl die Behandlung bereits existierender Beeinträchtigungen (insbesondere durch unerwünschte, bakteriell verursachte Gerüche) als auch die entsprechende Prophylaxe-of the human and animal body, which is affected by the Gram-positive bacteria to be controlled. The form of application depends crucially on the dosage form of the compound of formula I to be used (see below). Although the method according to the invention will generally serve cosmetic purposes, there is also a therapeutic purpose in some cases. The term “control” encompasses both the treatment of existing impairments (in particular by undesirable, bacterially caused odors) and the corresponding prophylaxis.
Die Herstellung der erfindungsgemäß einzusetzenden sekundären Alkohole der Formel I worin R1 = H und m, n = 0 ist, gelingt nach Schema 1.The preparation of the secondary alcohols of the formula I to be used according to the invention in which R 1 = H and m, n = 0 succeeds according to scheme 1.
Schema 1Scheme 1
Figure imgf000012_0001
Figure imgf000012_0001
Die Herstellung der erfindungsgemäß einzusetzenden sekundären Alkohole der Formel (I) worin R1 = H ; R3 = H und m = 0,1 ist, gelingt nach Schema 2 The preparation of the secondary alcohols of the formula (I) to be used according to the invention in which R 1 = H; R 3 = H and m = 0.1, succeed according to scheme 2
Schema 2Scheme 2
Figure imgf000013_0001
Figure imgf000013_0001
Hydrierung/ Reduktion
Figure imgf000013_0002
Hydrogenation / reduction
Figure imgf000013_0002
Die Herstellung der erfindungsgemäß einzusetzenden sekundären Alkohole der Formel (l) worin R1 = H ; R3 = H ; R5 = H ist, gelingt nach Schema 3The preparation of the secondary alcohols of the formula (I) in which R 1 = H; R 3 = H; R 5 = H, succeeds according to scheme 3
Schema 3Scheme 3
Figure imgf000013_0003
Figure imgf000013_0003
Figure imgf000013_0004
Figure imgf000013_0004
Durch eine Aldolreaktion eines geeigneten Aldehydes mit einem Methyiketon wird zunächst ein α,ß-ungesättigtes Keton hergestellt (J. March, Advanced Organic Chemistiy, 4 ed., J. Wiley, New York, 1992, S. 937-944). In einem nachfolgenden Schritt werden die Doppelbindung und die Ketogruppe hydriert. Gegebenenfalls kann auch zunächst nur die Doppelbindung hydriert und dann die Ketogruppe reduziert werden (J. March, Advanced Organic Chemistry, 4*1 ed., J. Wiley, New York, 1992, S. 771-783; 910-920) . Ein geeigneter Aldehyd wird in einer Grignard-Reaktion mit einem Methylmagnesiumhalogenid umgesetzt (J. March, Advanced Organic Chemistry, 4lh ed., J. Wiley, New York, 1992, S. 920-931). Bei enthaltenen Doppelbindungen können die entsprechenden gesättigten Verbindungen durch katalytische Hydrierung erhalten werden (Schema 4).An α, β-unsaturated ketone is first prepared by an aldol reaction of a suitable aldehyde with a methyl ketone (J. March, Advanced Organic Chemistry, 4 ed., J. Wiley, New York, 1992, pp. 937-944). In a subsequent step, the double bond and the keto group are hydrogenated. If necessary, only the double bond can be hydrogenated first and then the keto group can be reduced (J. March, Advanced Organic Chemistry, 4 * 1 ed., J. Wiley, New York, 1992, pp. 771-783; 910-920). A suitable aldehyde is reacted in a Grignard reaction with a methyl magnesium halide (J. March, Advanced Organic Chemistry, 4 lh ed., J. Wiley, New York, 1992, pp. 920-931). If double bonds are present, the corresponding saturated compounds can be obtained by catalytic hydrogenation (Scheme 4).
Schema 4Scheme 4
Figure imgf000014_0001
Figure imgf000014_0001
Erfindungsgemäße Zubereitungen, insbesondere kosmetische, mundhygienische und dermatologische Zubereitungen, umfassen eine antibakteriell wirksame Menge einer Verbindung der Formel I (wobei die vorstehenden Angaben zu den Substituenten und den bevorzugten Verbindungen entsprechend gelten), sowie zumindest einen weiteren Bestandteil, der für eine z. B. kosmetische, mundhygienische oder dermatologische Zubereitung typisch ist. In diesem Zusammenhang sei mit Blick auf die bereits diskutierte EP 0919607 A2 darauf hingewiesen, Preparations according to the invention, in particular cosmetic, oral hygiene and dermatological preparations, comprise an antibacterially effective amount of a compound of the formula I (the information above regarding the substituents and the preferred compounds correspondingly apply), and at least one further ingredient which is suitable for a z. B. cosmetic, oral hygiene or dermatological preparation is typical. In this context, with reference to EP 0919607 A2 already discussed, it should be pointed out that
dass die erfindungsgemäßen Zubereitungen üblicherweise nicht als Schmierstoff für die mechanische Bearbeitung bzw. Verarbeitung von Werkstoffen eingesetzt werden können. Insbesondere enthalten die erfindungsgemäßen Zubereitungen in der Regel keinen Korrosionsinhibitor (organische Borverbindungen), keinen EP-Wirkstoff (Schwefel- und Phosphor- Additive), keinen Entschäumer, keinen Formaldehydabspalter und keine Borsäure-that the preparations according to the invention cannot usually be used as a lubricant for the mechanical processing or processing of materials. In particular, the preparations according to the invention generally do not contain any corrosion inhibitor (organic boron compounds), no EP active ingredient (sulfur and phosphorus additives), no defoamer, no formaldehyde releaser and no boric acid
Die erfindungsgemäß zu verwendenden Verbindungen der Formel I können auch eingesetzt werden, um den Verderb organischer Substanzen und Zubereitungen, insbesondere den Verderb kosmetischer, dermatologischer und mundhygienischer Zubereitungen, durch den Befall mit Gram-positiven Bakterien zu verhindern- In einem entsprechenden erfindungsgemäßen Verfahren zum Verhindern des Befalls einer kosmetischen und therapeutischen Formulierung mit Grampositiven Bakterien wird die Formulierung mit einer antibakteriell wirksamen Menge einer oder mehrerer Verbindungen der Formel I vermischt, wobei die oben gemachten Ausführungen zu den Substituenten und den bevorzugt einzusetzenden Verbindungen der Formel I entsprechend gelten. Vorzugsweise werden die Verbindungen der Formel I in einer Konzentration von 0,05 - 10 Gew.-% eingesetzt, bezogen auf die Gesamtmasse der Substanz oder Formulierung-The compounds of formula I to be used according to the invention can also be used to prevent the spoilage of organic substances and preparations, in particular the spoilage of cosmetic, dermatological and oral hygiene preparations, by infestation with gram-positive bacteria. In a corresponding method according to the invention for preventing the If a cosmetic and therapeutic formulation is infected with gram-positive bacteria, the formulation is mixed with an antibacterially effective amount of one or more compounds of the formula I, the statements made above regarding the substituents and the compounds of the formula I to be used with preference apply accordingly. The compounds of the formula I are preferably used in a concentration of 0.05-10% by weight, based on the total mass of the substance or formulation.
Die sekundären Alkohole der Formel (I) harmonieren -wie erwähnt - mit einer großen Vielzahl an üblichen kosmetischen Hilfs- und Zusatzstoffen, und zwar vor allem auch deshalb, weil die Verbindungen der Formel (I) keinen bzw. nur einen sehr geringen Eigengeruch aufweisen. Dies gilt insbesondere für die in desodorierend oder antitranspirierend wirkenden Formulierungen üblichenAs mentioned, the secondary alcohols of the formula (I) harmonize with a large number of customary cosmetic auxiliaries and additives, above all because the compounds of the formula (I) have no or only a very slight odor. This applies in particular to the formulations which are customary in deodorant or antiperspirant formulations
Parfümbestandteile- Auch die Kombination von Adstringentien, vorwiegend Aluminiumsalzen wie Aluminiumhydroxychlorid, mit den erfindungsgemaß antimikrobiell wirksamen Stoffen der Formel (I) in ein und derselben Zusammensetzung ist vorteilhaft. Perfume ingredients - The combination of astringents, predominantly aluminum salts such as aluminum hydroxychloride, with the antimicrobial substances according to the invention of the formula (I) in one and the same composition is also advantageous.
Es können ein oder mehrere antimikrobiell wirksame Verbindungen der Formel (I) in Zubereitungen eingesetzt werden- Der Gesamtgehalt an erfindungsgemäßen sekundären Alkoholen liegt üblicherweise im Bereich von 0,005 bis 50 Gew.-%, bevorzugt im Bereich von 0,01 bis 20 Gew.-%, besonders bevorzugt 0,1 bis 5 Gew.-% an den erfindungsgemäßen Verbindungen, und ganz besonders bevorzugt 0,5 bis 3 Gew.-%, bezogen auf das Gesamtgewicht der Zubereitung.One or more antimicrobial compounds of the formula (I) can be used in preparations. The total content of secondary alcohols according to the invention is usually in the range from 0.005 to 50% by weight, preferably in the range from 0.01 to 20% by weight. , particularly preferably 0.1 to 5% by weight of the compounds according to the invention, and very particularly preferably 0.5 to 3% by weight, based on the total weight of the preparation.
Die Verbindungen der Formel (I) werden bevorzugt in kosmetischen, mundhygienischen oder dermatologischen Zubereitungen eingesetzt. Die erfindungsgemäßen Verbindungen lassen sich ohne Schwierigkeiten in gängige kosmetische, mundhygienische oder dermatologische Zubereitungen einarbeiten, vorteilhaft in Pumpsprays, Aerosolsprays, Cremes, Salben, Tinkturen, Lotionen, Zahnpasten, Mundwässer, Zahngele, Nagelpflegeprodukte (z.B. Nagellacke, Nagellackentferner, Nagelbalsame) und dergleichen-The compounds of formula (I) are preferably used in cosmetic, oral hygiene or dermatological preparations. The compounds according to the invention can be incorporated without difficulty into common cosmetic, oral hygiene or dermatological preparations, advantageously in pump sprays, aerosol sprays, creams, ointments, tinctures, lotions, toothpastes, mouthwashes, tooth gels, nail care products (e.g. nail polishes, nail polish removers, nail balms) and the like -
Die erfindungsgemäßen Verbindungen können auch mikroverkapselt, sprühgetrocknet, als Einschluß-Komplexe oder als Extrusions-Produkte vorliegen und in dieser Form verwendet und beispielsweise in Formulierungen eingearbeitet werden- Gegebenenfalls können die Eigenschaften der derart modifizierten Wirkstoffe durch sogenanntes "Coaten" mit geeigneten Materialien im Hinblick auf eine gezieltere Freisetzung weiter optimiert werden, wozu vorzugsweise wachsartige Kunststoffe wie z.B. Poiyvinylalkohol verwendet werden- Die Mikroverkapselung der Wirkstoffe kann beispielsweise durch das sogenannte Koazervationsverfahren mit Hilfe von Kapselmaterialien z.B. aus polyurethan-artigen Stoffen oder Weichgelatine, erfolgen- Die sprühgetrockneten Wirkstoffe können beispielsweise durch The compounds according to the invention can also be microencapsulated, spray-dried, present as inclusion complexes or as extrusion products and used in this form and incorporated, for example, in formulations. If appropriate, the properties of the active compounds modified in this way can be modified by so-called "coating" with suitable materials a more targeted release can be further optimized, for which purpose wax-like plastics such as, for example, polyvinyl alcohol are preferably used. The microencapsulation of the active compounds can be carried out, for example, by the so-called coacervation process with the aid of capsule materials, for example made of polyurethane-like substances or soft gelatin
Sprühtrocknung einer den Wirkstoff enthaltenden Emulsion, bzw. Dispersion hergestellt werden, wobei als Trägerstoffe modifizierte Stärken, Proteine, Dextrin und pflanzliche Gummen verwendet werden können. Einschluß-Komplexe können z.B. durch Eintragen von Dispersionen von dem Wirkstoff und Cyclodextrinen oder Harnstoffderivaten in ein geeignetes Lösungsmittel, z.B. Wasser, hergestellt werden. Extrusions-Produkte können durch Verschmelzen der Wirkstoffe mit einem geeigneten wachsartigen Stoff und durch Extru- sion mit nachfolgender Erstarrung, ggf. in einem geeigneten Lösungsmittel, z.B. Isopropanol, erfolgen-Spray drying of an emulsion or dispersion containing the active ingredient can be produced, whereby modified starches, proteins, dextrin and vegetable gums can be used as carriers. Inclusion complexes can e.g. by adding dispersions of the active ingredient and cyclodextrins or urea derivatives in a suitable solvent, e.g. Water. Extrusion products can be obtained by fusing the active ingredients with a suitable waxy substance and by extrusion with subsequent solidification, if appropriate in a suitable solvent, e.g. Isopropanol,
Es ist auch möglich und gegebenenfalls vorteilhaft, die erfindungsgemäß einzusetzenden Verbindungen der Formel (I) mit anderen kosmetischen, mundhygienischen und/oder dermatologischen Wirkstoffen zu kombinieren, beispielsweise mit anderen antimikrobiell, antimycotisch bzw. antiviral wirksamen Stoffen.It is also possible and possibly advantageous to combine the compounds of the formula (I) to be used according to the invention with other cosmetic, oral hygiene and / or dermatological active substances, for example with other antimicrobial, antimycotic or antiviral substances.
Erfindungsgemäße Zubereitungen können Hilfsstoffe enthalten, wie sie üblicherweise in kosmetischen oder therapeutischen Zubereitungen verwendet werden, z.B. Konservierungsmittel, Abrasiva, anitbakterielle Mittel, entzündungshemmende Mittel, irritationsverhindernde Mittel, irritationshemmende Mittel, antimikrobielle Mittel, Antioxidantien, Adstringentien, antiseptische Mittel, Antistatika, Binder, Puffer, Trägermaterialien, Chelatbildnder, Zellstimulantien, reinigende Mittel, pflegende Mittel, oberflächenaktive Substanzen, deodorierende Mittel, Weichmacher, Bakterizide, Emulgatoren, Enzyme, ätherische Öle, Filmbildner, Fixateure, Schaumbildner, Schaumstabilisatoren, Substanzen zum Verhindern des Schäumens, Schaumbooster, gelierende Mittel, gelbildende Mittel, feuchtigkeitsspendende Mittel, anfeuchtende Substanzen, feuchthaltende Substanzen, bleichende Mittel, optisch aufhellende Mittel, schmutzabweisende Mittel, reibungsverringernde Mittel, Gleitmittel, Trübungsmittel, deckfähige Mittel, Glanzmittel, Polymere, Pulver, Proteine, abschleifende Mittel, Preparations according to the invention can contain auxiliaries of the kind normally used in cosmetic or therapeutic preparations, for example preservatives, abrasives, antibacterial agents, anti-inflammatory agents, anti-irritants, anti-irritants, antimicrobials, antioxidants, astringents, antiseptics, antistatic agents, binders, buffers, buffers, buffers, buffers. Carrier materials, chelating agents, cell stimulants, cleaning agents, caring agents, surface-active substances, deodorising agents, plasticizers, bactericides, emulsifiers, enzymes, essential oils, film formers, fixatives, foaming agents, foam stabilizers, substances for preventing foaming, foam boosters, gelling agents , moisturizing agents, moisturizing substances, moisturizing substances, bleaching agents, optically brightening agents, dirt-repellent agents, friction-reducing agents, lubricants, opacifiers, opaque agents, brighteners, polymers, powders, proteins, abrasives,
Silicone, hautberuhigende Mittel, hautreinigende Mittel, hautpflegende Mittel, hautheilende Mittel, kühlende Mittel, hautkühlende Mittel, wärmende Mittel, hautwärmende Mittel, Stabilisatoren, UV- absorbierende Mittel, UV-Filter, suspendierende Mittel, Verdickungsmittel, Vitamine, Öle, Wachse, Fette, Phospholipide, gesättigte Fettsäuren, ein- oder mehrfach ungesättigte Fettsäuren, α- Hydroxysäuren, Polyhydroxyfettsäuren, Verflüssiger, Farbstoffe, farbschützende Mittel, Pigmente, Aromen, Geschmackstoffe, Parfüms, Riechstoffe oder andere übliche Bestandteile solcher Zubereitungen wie Alkohole, Polyole, Elektrolyte, organische Lösungsmittel oder Silikonderivate-Silicones, skin soothing agents, skin cleansing agents, skin care agents, skin healing agents, cooling agents, skin cooling agents, warming agents, skin warming agents, stabilizers, UV absorbing agents, UV filters, suspending agents, thickening agents, vitamins, oils, waxes, fats, Phospholipids, saturated fatty acids, mono- or polyunsaturated fatty acids, α-hydroxy acids, polyhydroxy fatty acids, plasticizers, dyes, color-protecting agents, pigments, flavors, flavorings, perfumes, fragrances or other common components of such preparations such as alcohols, polyols, electrolytes, organic solvents or Silikonderivate-
Riech- und Geschmackstoffe, die sich mit den sekundären Alkoholen der Formel (I) in kosmetischen, mundhygienischen oder dermatologischen Zubereitungen kombinieren lassen, finden sich beispielsweise in Bauer, Garbe, Surburg, Common Fragrance and Flavor Materials, Wiley-VCH, 4. Aufl., 2001 oder in S. Arctander, Perfume and Flavor Chemicals, Vol. I und II, Montclair, N. J., 1969, Selbstverlag.Fragrances and flavors that can be combined with the secondary alcohols of the formula (I) in cosmetic, oral hygiene or dermatological preparations can be found, for example, in Bauer, Garbe, Surburg, Common Fragrance and Flavor Materials, Wiley-VCH, 4th ed. , 2001 or in S. Arctander, Perfume and Flavor Chemicals, Vol. I and II, Montclair, NJ, 1969, self-published.
Darüber hinaus können erfindungsgemäße Zubereitungen zudem UV- Absorber (UV-Filter) wie z.B. Neo Heiiopane® zum Schutz vor Sonneneinstrahlung enthalten. Geeignete Lichtschutzmittel sind z.B. organische UV-Absorber aus der Klasse der 4-Aminobenzoesäure und Derivate, Salicylsäure-Derivate, Benzophenon-Derivatθ,Moreover, the preparations according to the invention can also UV absorbers (UV filters) such as Neo Heiiopane ® contain such protection from sunlight. Suitable light stabilizers are, for example, organic UV absorbers from the class of 4-aminobenzoic acid and derivatives, salicylic acid derivatives, benzophenone derivatives,
Dibenzoylmethan-Derivate, Diphenylacrylate, 3-lmidazol-4-yl-acrylsäure und deren Ester, Benzofuran-Derivate, Benzylidenmalonat-Deriva-te, polymere UV-Absorber, enthaltend einen oder mehrere Siliziumorganische Reste, Zimtsäure-Derivate, Campher-Derivate, Trianilino-s- Triazin-Derivate, 2-Hydroxyphenylbenzotriazol-Derivate, 2-Dibenzoylmethane derivatives, diphenylacrylates, 3-imidazol-4-yl-acrylic acid and their esters, benzofuran derivatives, benzylidene malonate derivatives, polymeric UV absorbers, containing one or more organosilicon residues, cinnamic acid derivatives, camphor derivatives, trianilino -s- triazine derivatives, 2-hydroxyphenylbenzotriazole derivatives, 2-
Phenylbenzimidazol-5-sulfonsäure und deren Salze, Anthranilsäure- menthylester, Benzotriazolderivate. Phenylbenzimidazole-5-sulfonic acid and its salts, anthranilic acid menthyl ester, benzotriazole derivatives.
Die Liste der nachfolgend genannten UV-Absorber, die vorteilhaft in erfindungsgemäßen Zubereitungen eingesetzt werden können, soll selbstverständlich nicht limitierend sein: 4-Aminobenzoesäure, 4- Aminobenzoesäureethylester, 4-DimethyIaminobenzoesäure-2-ethyl- hexylester, 4-Aminobenzoesäureglycerinester, Salicylsäure-homo- menthylester (Homosalate), Salicylsäure-2-ethylhexyIester,The list of UV absorbers mentioned below, which can advantageously be used in preparations according to the invention, is of course not intended to be limiting: 4-aminobenzoic acid, 4-aminobenzoic acid ethyl ester, 4-dimethylaminobenzoic acid 2-ethylhexyl ester, 4-aminobenzoic acid glycerol ester, salicylic acid homo- menthyl esters (homosalates), salicylic acid 2-ethylhexyl ester,
Triethaπolamin-salicylat, 4-lsopropylbenzylsalicylat,Triethanolamine salicylate, 4-isopropylbenzyl salicylate,
Anthranilsäurementhylester, Diisopropyl-zimtsäureethylester, p- Methoxyzimtsäure-2-ethylhexylester, Diisopropylzimt-säuremethylester, p-Methoxyzimtsäureisoamylester, p-Methoxyzimtsäure-di- ethanolaminsalz, p-Methoxyzimtsäure-isopropylester, 2-Ethylhexyl-2- cyano-3,3-diphenylacrylat, Ethyl-2-cyano-3,3'-diphenyIacrylat, 2- Phenylbenzimidazol-5-sul-fonsäure und deren Salze, 3-(4'- Trimethylammonium)-beπzyliden-bornan-2-on-methylsulfat, Terephthalyliden-dibornansulfonsäure und Salze, 4-t-Butyl-4'-me-thoxy- dibenzoylmethan, ß-lmidazol-4(5)-acrylsäure (Urocaninsäure), 2- Hydroxy-4-methoxybenzophenon, 2-Hydroxy-4-methoxybenzophenon-5- sulfonsäure, Di-hydroxy-4-methoxybenzophenon, 2,4-Anthranilsäurementhylester, ethyl diisopropyl cinnamate, 2-ethylhexyl p-methoxy cinnamate, methyl diisopropyl cinnamate, isoamyl p-methoxy cinnamate, di-ethanol amine p-methoxy cinnamate, 3,3-isano-ethyl-p-methoxy cinnamate, 2-isano-ethyl p-methoxy cinnamate Ethyl-2-cyano-3,3'-diphenyl acrylate, 2-phenylbenzimidazole-5-sulphonic acid and its salts, 3- (4'-trimethylammonium) -benzzylidenebornan-2-one-methylsulfate, terephthalylidene-dibornanesulfonic acid and salts , 4-t-butyl-4'-methoxy-dibenzoylmethane, ß-imidazole-4 (5) -acrylic acid (urocanic acid), 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid, Di-hydroxy-4-methoxybenzophenone, 2,4-
Dihydroxybenzophenon, Tetrahydroxyben-zophenon, 2,2'-Dihydroxy- 4,4'-dimethoxybenzophenon, 2-Hydroxy-4-n-octoxy-benzophenon, 2- Hydroxy-4-melhoxy-4'-methylbenzophenon, '37(4'-Sulfo)benzyI-iden- bornan-2-on und deren Salze, 3-(4'-Methylbenzyliden)campher, 3- Benzyl-idencampher, 3,3'-(1,4-Phenylenedimethine)-bis-(7,7-dimethyl-2- oxo-bicyclo-[2.2.1]heptane-1-methansulfonsäure und deren Salze, 4- Isopropyldibenzoyl-methan, 2,4,6-Trianilino-(p-carbo-2'-ethylhexyl-1'- oxy)-1 ,3,5-triazin, Phenylen-1 ,4-bis-(2-benzimidazyl)-3,3'-5,5'- tetrasulfonsäure und deren Salze, besonders die entsprechenden Natrium, Kalium- oder Trierthanolammonium-Salze, insbesondere das Dinatriumsalz, 2,2'-(1 ,4-Phenylen)-bis-(1 H-benzimidazol-4,6- disulfonsäure), Mononatriumsalz, N-[(2 und 4)-[2-(oxobom-3- yliden)methyl]ben-zyl]-acrylamid-Polymer, Phenol, 2-(2H-benzotriazol-2- yl)-4-methyl-6-(2-methyl-3(1,3,3,3-tetramethyl-1-(trimethylsiIyl)-oxy)- disiloxyanyl)-propyl), 4,4'-[(6-[4-(1 , 1 -Dimethyl)-aminocarbonyl)- Dihydroxybenzophenone, tetrahydroxybenzophenone, 2,2'-dihydroxy-4,4'-dimethoxybenzophenone, 2-hydroxy-4-n-octoxy-benzophenone, 2-hydroxy-4-melhoxy-4'-methylbenzophenone, '37 (4 ' -Sulfo) benzyI-iden- bornan-2-one and its salts, 3- (4'-methylbenzylidene) camphor, 3-benzyl-idencampher, 3,3 '- (1,4-phenylenedimethine) -bis- (7, 7-dimethyl-2-oxo-bicyclo- [2.2.1] heptane-1-methanesulfonic acid and its salts, 4-isopropyldibenzoyl-methane, 2,4,6-trianilino- (p-carbo-2'-ethylhexyl-1 ' - oxy) -1, 3,5-triazine, phenylene-1, 4-bis- (2-benzimidazyl) -3,3'-5,5'-tetrasulfonic acid and its salts, especially the corresponding sodium, potassium or tri-ethanolamine Salts, in particular the disodium salt, 2,2 '- (1,4-phenylene) -bis- (1 H -benzimidazole-4,6-disulfonic acid), monosodium salt, N - [(2 and 4) - [2- ( oxobom-3-ylidene) methyl] benzyl] acrylamide polymer, phenol, 2- (2H-benzotriazol-2-yl) -4-methyl-6- (2-methyl-3 (1,3,3, 3-tetramethyl-1- (trimethylsilyl) oxy) disiloxyanyl) propyl), 4,4 '- [(6- [4- (1,1, dimethyl) aminocarbonyl) -
phenylamino]-1,3,5-triazin-2,4-diyl)diimino]-bis-(benzoesäure-2- ethylhexylester), 2,2'-Methylen-bis-(6-(2H-benztriazol-2-yl)-4-1 , 1 ,3,3- tetramethylbutyl)-phenol), 2,4-bis-[4-(2-ethylhexyloxy)-2-hydroxyphenyl]- 1,3,5-triazin, Benzylidenmalonat-Polysiloxan, Glyceryl-ethylhexaπoat- dimethoxy-cinnamat, Dinatrium-2,2'-dihydroxy-4,4'-dimethoxy-5,5'- disulfo-benzophenon, Dipropylenglykolsalicylat, Natrium- hydroxymethoxybenzophenon-suifonat, 4,4',4-(1 ,3,5-Triazin-2,4,6- triyltriimino)-tris-benzoesäure-tris(2-ethylhexylester), 2,4-Bis-[{(4-(2- Ethyl-hexyloxy)-2-hydroxy}-phenyl]-6-(4-methoxyphenyl)-1,3,5-triazin, 2,4-Bis-[{(4-(3-sulfonato)-2-hydroxy-propyloxy)-2-hydroxy}-phenyl]-6-(4- methoxyphenyl)-1,3,5-triazin-Natriumsalz, 2,4-Bis-[{(3-(2-Propyloxy)-2- hy-droxy-propyloxy)-2-hydroxy}-phenyl]-6-(4-methoxy-phenyl)-1,3,5- triazin, 2,4-Bis-[{4-(2-Ethyl-hexyioxy)-2-hydroxy}-phenyl]-6-[4-(2- methoxyethyl-carbonyl)-phenyI-amino]-1,3,5-triazin, 2,4-Bis-[{4-(3-(2- propyloxy)-2-hydroxy-propyloxy)-2-hydro-xy}-phenyl]-6-[4-(2- ethylcarboxyl)-phenylamino]-1,3,5-triazin, 2,4-Bis-[{4-(2-Ethyl-hexyloxy)- 2-hydroxy}-phenyI]-6-(1 -methyl-pyrrol-2-yl-)-1 ,3,5-triazin, 2,4-Bis-[{4- tris-(trimethylsiloxy-silylpropylθ3ty)-2-hydroxy}-phenyl]-6-(4- methoxyphenyl)-1 ,3,5- triazin, 2,4-Bis-[{4-(2"-Methylpropenylθ55y)-2- hydroxy}-phenyl]-6-(4-me-thoxyphenyl)-1,3,5-triazin, 2,4-Bis-[{4-phenylamino] -1,3,5-triazine-2,4-diyl) diimino] bis (2-ethylhexyl benzoate), 2,2'-methylene-bis- (6- (2H-benzotriazol-2-yl ) -4-1, 1, 3,3-tetramethylbutyl) phenol), 2,4-bis- [4- (2-ethylhexyloxy) -2-hydroxyphenyl] - 1,3,5-triazine, benzylidene malonate polysiloxane, Glyceryl ethyl hexao-dimethoxy cinnamate, disodium 2,2'-dihydroxy-4,4'-dimethoxy-5,5'-disulfo-benzophenone, dipropylene glycol salicylate, sodium hydroxymethoxybenzophenone suifonate, 4,4 ', 4- (1 , 3,5-triazine-2,4,6-triyltriimino) tris-benzoic acid tris (2-ethylhexyl ester), 2,4-bis - [{(4- (2-ethylhexyloxy) -2-hydroxy} -phenyl] -6- (4-methoxyphenyl) -1,3,5-triazine, 2,4-bis - [{(4- (3-sulfonato) -2-hydroxypropyloxy) -2-hydroxy} phenyl ] -6- (4-methoxyphenyl) -1,3,5-triazine sodium salt, 2,4-bis - [{(3- (2-propyloxy) -2-hydroxy-propyloxy) -2-hydroxy} -phenyl] -6- (4-methoxyphenyl) -1,3,5-triazine, 2,4-bis - [{4- (2-ethylhexyioxy) -2-hydroxy} phenyl] -6- [4- (2-methoxyethylcarbonyl) phenyl amino] -1,3,5-triazine, 2,4-bis - [{4- (3- (2-propyloxy) -2-hydroxypropylox y) -2-hydro-xy} phenyl] -6- [4- (2-ethylcarboxyl) phenylamino] -1,3,5-triazine, 2,4-bis - [{4- (2-ethyl- hexyloxy) - 2-hydroxy} -phenyI] -6- (1-methyl-pyrrol-2-yl -) - 1, 3,5-triazine, 2,4-bis - [{4-tris (trimethylsiloxysilylpropylθ3ty ) -2-hydroxy} phenyl] -6- (4-methoxyphenyl) -1, 3,5-triazine, 2,4-bis - [{4- (2 "-methylpropenylθ55y) -2-hydroxy} phenyl] -6- (4-methoxyphenyl) -1,3,5-triazine, 2,4-bis - [{4-
(1 ', 1 ', 1 ',3'5',5',5'-Heptamethylsiloxy-2"-methyl-propyloxy)-2-hydroxy}- phenyl]-6-(4-methoxyphenyl)-1,3,5-triazin.(1 ', 1', 1 ', 3'5', 5 ', 5'-heptamethylsiloxy-2 "-methyl-propyloxy) -2-hydroxy} phenyl] -6- (4-methoxyphenyl) -1,3 , 5-triazine.
Die Menge nicht-partikulärer UV-Absorber (eine oder mehrere Verbindungen) in erfindungsgemäßen Zubereitungen beträgt vorzugsweise 0,001 bis 30 Gew.-%, Die Gesamtmenge der Filtersubstanzen beträgt vorzugsweise 0,1 bis 30 Gew.-%, besonders bevorzugt 0,2 bis 10 Gew.-%, insbesondere 0,5 bis 8 Gew.-%, bezogen auf das Gesamtgewicht der Zubereitung- The amount of non-particulate UV absorber (one or more compounds) in preparations according to the invention is preferably 0.001 to 30% by weight. The total amount of filter substances is preferably 0.1 to 30% by weight, particularly preferably 0.2 to 10 % By weight, in particular 0.5 to 8% by weight, based on the total weight of the preparation.
Es können darüber hinaus partikuläre UV-Filter oder anorganische Pigmente eingesetzt werden, die gegebenenfalls hydrophobisiert sein können, wie die Oxide des Titans (Tiθ2), Zinks (ZnO), Eisens (Fe2θ3), Zirkoniums (Zr02), Siliciums (Siθ2), Mangans (z.B. MnO), Aluminiums (AI2θ3), Cers (z.B. Ce2θ3) und/oder Mischungen davon.In addition, particulate UV filters or inorganic pigments can be used, which can optionally be hydrophobized, such as the oxides of titanium (TiO 2 ), zinc (ZnO), iron (Fe 2 O 3 ), zirconium (ZrO 2 ), silicon (SiO 2 ), manganese (for example MnO), aluminum (Al 2 O 3 ), cerium (for example Ce 2 O 3 ) and / or mixtures thereof.
Für kosmetische und/oder dermatologische Anwendungen geeigneten und/oder gebräuchlichen Antioxidantien können in den erfindungsgemäßen Zubereitungen verwendet werden-Antioxidants suitable and / or customary for cosmetic and / or dermatological applications can be used in the preparations according to the invention.
Vorteilhaft werden die Antioxidantien gewählt aus der Gruppe bestehend aus Aminosäuren (z.B. Glycin, Histidin, Tyrosin, Tryptophan) und deren Derivate, Imidazole (z.B. Urocaninsäure) und deren Derivate, Peptide wie D,L-Carnosin, D-Carnosin, L-Camosin und deren Derivate (z.B. Anserin), Carotinoide, Carotine (z.B. α-Carotin, ß-Carotin, Lycopin) und deren Derivate, Liponsäure und deren Derivate (z.B. Dihydroliponsäure), Aurothioglucose, Propylthiouracil und andere Thiole (z.B. Thioredoxin, Glutathion, Cystein, Cystin, Cystamin und deren Giycosyl-, N-Acetyl-, Methyl-, Ethyl-, Propyl-, Amyl-, Butyl- und Lauryl-, Palmitoyl-, Oleyl-, γ- Linoieyl-, Choleεteryl- und Glycerylester) sowie deren Salze, Diiaurylthiodipropionat, Distearylthiodipropionat, Thiodipropionsäure und deren Derivate (Ester, Ether, Peptide, Lipide, Nukleotide, Nukleoside und Salze) sowie Sulfoximinverbindungen (z.B. Buthioninsulfoximine, Homocysteiπsulfoximin, Buthioninsulfone, Penta-, Hexa-, Heptathio- ninsulfoximin) in sehr geringen verträglichen Dosierungen (z.B. pmol bis μmol/kg), ferner (Metall)-Chelatoren (z.B. α-Hydroxyfettsäuren, Pal- mitinsäure, Phytinsäure, Lactoferrin), α-Hydroxysäuren (z.B. Zitronensäure, Milchsäure, Apfelsäure), Huminsäure, Gallensäure, Gallenextrakte, Bilirubin, Biliverdin, EDTA, EGTA und deren Derivate, ungesättigte Fettsäuren und deren Derivate (z.B. γ-Linolensäure, Linolsäure, Ölsäure), Folsäure und deren Derivate, Ubichinon und Ubi- chiπol und deren Derivate, Vitamin C und Derivate (z.B. The antioxidants are advantageously selected from the group consisting of amino acids (e.g. glycine, histidine, tyrosine, tryptophan) and their derivatives, imidazoles (e.g. urocanic acid) and their derivatives, peptides such as D, L-carnosine, D-carnosine, L-camosine and their derivatives (e.g. anserine), carotenoids, carotenes (e.g. α-carotene, ß-carotene, lycopene) and their derivatives, lipoic acid and their derivatives (e.g. dihydroliponic acid), aurothioglucose, propylthiouracil and other thiols (e.g. thioredoxin, glutathione, cysteine, cystine , Cystamine and their glycosyl, N-acetyl, methyl, ethyl, propyl, amyl, butyl and lauryl, palmitoyl, oleyl, γ-lininoyl, choleεteryl and glyceryl esters) and their salts, Diiauryl thiodipropionate, distearyl thiodipropionate, thiodipropionic acid and their derivatives (esters, ethers, peptides, lipids, nucleotides, nucleosides and salts) as well as sulfoximine compounds (e.g. buthioninsulfoximines, homocysteine sulfoximines, buthioninsulfones, penta-, hexa-, heptoximinin), very achieve tolerable dosages (e.g. pmol to μmol / kg), also (metal) chelators (e.g. α-hydroxy fatty acids, palmitic acid, phytic acid, lactoferrin), α-hydroxy acids (e.g. citric acid, lactic acid, malic acid), humic acid, bile acid, bile extracts , Bilirubin, biliverdin, EDTA, EGTA and their derivatives, unsaturated fatty acids and their derivatives (e.g. γ-linolenic acid, linoleic acid, oleic acid), folic acid and their derivatives, ubiquinone and ubiquiole and their derivatives, vitamin C and derivatives (e.g.
Ascorbylpalmitat, Mg- Ascor bylphosphat, Ascorbylacetat), Tocopherole und Derivate (z.B. Vitamin E- acetat), Vitamin A und Derivate (Vitamin A - palmitat) sowie Konyferylbenzoat des Benzoeharzes, Rutinsäure und deren Derivate, Ferulasäure und deren Derivate, Butylhydroxytoluol, Bu- tylhydroxyanisol, Nordihydroguajakharzsäure, Nordihydroguajaretsäure, Trihydroxybutyrophenon, Harnsäure und deren Derivate, Mannose und deren Derivate, Zink und dessen Derivate (z.B. ZnO, ZnS04) Selen und dessen Derivate (z.B. Selenmethionin), Stilbene und deren Derivate (z.B. Stilbenoxid, Trans-Stilbenoxid) und die erfindungsgemäß geeigneten Derivate (Salze, Ester, Ether, Zucker, Nukleotide, Nukleo- side, Peptide und Lipide) dieser genannten Wirkstoffe- Die vorstehende Aufstellung ist nicht limitierend.Ascorbyl palmitate, Mg-Ascor byl phosphate, ascorbyl acetate), tocopherols and derivatives (e.g. vitamin E acetate), vitamin A and derivatives (vitamin A palmitate) as well as konyferyl benzoate of benzoin, rutinic acid and its derivatives, ferulic acid and its derivatives, butylated hydroxytoluene, Bu- tylhydroxyanisole, nordihydroguajakh resinic acid, nordihydroguajaretic acid, trihydroxybutyrophenone, uric acid and its derivatives, mannose and its derivatives, zinc and its derivatives (e.g. ZnO, ZnS0 4 ) selenium and its derivatives (e.g. selenomethionine), stilbenes and their derivatives (e.g. stilbene oxide), transbenzene and the derivatives suitable according to the invention (salts, esters, ethers, sugars, nucleotides, nucleosides, peptides and lipids) of these active substances mentioned. The above list is not limiting.
Die Menge der Antioxidantien (eine oder mehrere Verbindungen) in erfindungsgemäßen Zubereitungen beträgt vorzugsweise 0,001 bis 30 Gew.-%, besondere bevorzugt 0,05 bis 20 Gew.-%, insbesondere 1 bis 10 Gew.-%, bezogen auf das Gesamtgewicht der Zubereitung.The amount of the antioxidants (one or more compounds) in preparations according to the invention is preferably 0.001 to 30% by weight, particularly preferably 0.05 to 20% by weight, in particular 1 to 10% by weight, based on the total weight of the preparation ,
Sofern Vitamin E und/oder dessen Derivate das oder die Antioxidantien darstellen, ist es vorteilhaft, deren jeweilige Konzentration aus dem Bereich von 0,001 bis 10 Gew.-%, bezogen auf das Gesamtgewicht der Zubereitung, zu wählen.If vitamin E and / or its derivatives represent the antioxidant (s), it is advantageous to choose their respective concentration from the range from 0.001 to 10% by weight, based on the total weight of the preparation.
Sofern Vitamin A, bzw. Vitamin-A-Derivate, bzw. Carotine bzw. deren Derivate das oder die Antioxidantien darstellen, ist es vorteilhaft, deren jeweilige Konzentration aus dem Bereich von 0,001 bis 10 Gew.-%, bezogen auf das Gesamtgewicht der Zubereitung, zu wählen. Beispiele für oberflächenaktive Substanzen, die in erfindungsgemäßen Zubereitungen vorteilhaft verwendet werden können, sind herkömmliche Seifen, z.B. Fettsäuresalze des Natriums, Alkylsulfate, Alkylethersulfate, Alkan- und Alkylbenzolsulfonate, Sulfoacetate, Sulfobetaine, Sar- cosinate, Amidosulfobetaine, Sulfosuccinate, Sulfobernsteinsäure- If vitamin A or vitamin A derivatives or carotenes or their derivatives represent the antioxidant or antioxidants, it is advantageous for their respective concentration to be in the range from 0.001 to 10% by weight, based on the total weight of the preparation , to choose. Examples of surface-active substances which can advantageously be used in preparations according to the invention are conventional soaps, for example fatty acid salts of sodium, alkyl sulfates, alkyl ether sulfates, alkane and alkylbenzenesulfonates, sulfoacetates, sulfobetaines, sarcosinates, amidosulfobetaines, sulfosuccinates, sulfosuccinic acid
haibester, Alkylethercarboxylate, Eiweiß-Fettsäure-Kondensate, Alkylbetaine und Amidobetaine, Fettsäurealkanolamide, Polyglycolether- Derivate.haibester, alkyl ether carboxylates, protein-fatty acid condensates, alkyl betaines and amidobetaines, fatty acid alkanolamides, polyglycol ether derivatives.
Die oberflächenaktive Substanz kann in einer Konzentration zwischen 1 Gew.-% und 50 Gew.-% in dem Shampoonierungsmittel, bzw. der Wasch-, Dusch- oder Badezubereitung, vorliegen-The surface-active substance can be present in a concentration between 1% by weight and 50% by weight in the shampooing agent, or in the washing, showering or bathing preparation.
Erfindungsgemäße kosmetische und dermatologische Zubereitungen können in verschiedenen Formen vorliegen, wie sie z.B. üblicherweise für diesen Typ von Zubereitungen eingesetzt werden. So können sie z.B. eine Lösung, eine Emulsion vom Typ Wasser-in-ÖI (W/O) oder vom Typ Öl-in-Wasser (O/W), oder eine multiple Emulsion, beispielsweise vom Typ Wasser-in-ÖI-in-Wasser (W/O/W), ein Gel, eine Hydro- dispersion, einen festen Stift oder auch ein Aerosol darstellen-Cosmetic and dermatological preparations according to the invention can be in various forms, such as those e.g. are usually used for this type of preparation. So you can e.g. a solution, an emulsion of the type water-in-oil (W / O) or of the type oil-in-water (O / W), or a multiple emulsion, for example of the type water-in-oil-in-water (W / O / W), a gel, a hydro-dispersion, a solid stick or an aerosol
Sofern die erfindungsgemäße kosmetische oder dermatologische Zubereitung eine Lösung oder Lotion darstellt, können als Lösungsmittel verwendet werden: Wasser oder wässrige Lösungen; Öle, wie Triglyceride der Caprin- oder der Caprylsäure, vorzugsweise aber Rizinusöl; - Fette, Wachse und andere natürliche und synthetische Fettkörper, vorzugsweise Ester von Fettsäuren mit Alkoholen niedriger C-Zahl, z.B. mit Isoprapanol, Propylenglykol oder Glycerin, oder Ester von Fettalkoholen mit Alkansäuren niedriger C-Zahl oder mit Fettsäuren; - Alkohole, Diole oder Polyole niedriger C-Zahl, sowie deren Ether, vorzugsweise Ethanol, Isoprapanol, Propylenglykol, Glycerin, Ethylenglykol, Ethylenglykolmonoethyl- oder -monobutylether, If the cosmetic or dermatological preparation according to the invention is a solution or lotion, the following can be used as solvents: water or aqueous solutions; Oils, such as triglycerides of capric or caprylic acid, but preferably castor oil; - Fats, waxes and other natural and synthetic fat bodies, preferably esters of fatty acids with alcohols with a low C number, for example with isoprapanol, propylene glycol or glycerol, or esters of fatty alcohols with alkanoic acids with a low C number or with fatty acids; Alcohols, diols or polyols of low C number, and their ethers, preferably ethanol, isoprapanol, propylene glycol, glycerol, ethylene glycol, ethylene glycol monoethyl or monobutyl ether,
Propylenglykolmonomethyl, -monoethyl- oder -monobutylether, Diethylenglykolmonomethyl- oder -monoethylether und analoge Produkte.Propylene glycol monomethyl, monoethyl or monobutyl ether, diethylene glycol monomethyl or monoethyl ether and similar products.
Insbesondere werden Gemische der vorstehend genannten Lö- sungsmittel verwendet. Bei alkoholischen Lösungsmitteln kann Wasser ein weiterer Bestandteil sein.Mixtures of the abovementioned solvents are used in particular. Water can also be a component of alcoholic solvents.
Erfindungsgemäße Zubereitungen sind oft vorzugsweise Emulsionen und enthalten z.B. die genannten Fette, Öle, Wachse und anderen Fettkörper, sowie Wasser und einen Emulgator, wie er üblicherweise für einen solchen Typ der Formulierung verwendet wird.Preparations according to the invention are often preferably emulsions and contain e.g. the fats, oils, waxes and other fat bodies mentioned, and also water and an emulsifier, as is usually used for such a type of formulation.
Erfindungsgemäße Zubereitungen können als Gele vorliegen und enthalten dann üblicherweise Alkohole niedriger C-Zahl, z.B. Ethanol, Isoprapanol, 1,2-Propandiol, Glycerin und Wasser bzw. ein vorstehend genanntes Öl in Gegenwart eines Verdickungsmittels, das bei ölig-alko- holischen Gelen vorzugsweise Siliciumdioxid oder ein Aluminiumsilikat, bei wäßrig-alkoholischen oder alkoholischen Gelen vorzugsweise ein Polyacrylat ist.Preparations according to the invention can be present as gels and then usually contain alcohols of low C number, e.g. Ethanol, isoprapanol, 1,2-propanediol, glycerol and water or an oil mentioned above in the presence of a thickener which is preferably silicon dioxide or an aluminum silicate in the case of oily-alcoholic gels, and is preferably a polyacrylate in the case of aqueous-alcoholic or alcoholic gels.
Erfiπdungsgemäße kosmetische und dermatologische Zubereitungen können als Gele vorliegen, die neben mindestens einer erfindungsgemäßen Verbindung und dafür üblicherweise verwendeten Lösungsmitteln noch organische Verdickungsmittel, z.B. Gummiarabikum, Xanthangummi, Natriumalginat, Cellulose-Derivate, vorzugsweise Methylcellulose, Hydroxymethylcellulose, Hydroxyethylcellulose, Hydroxypropylcellulose, Hydroxypropylmethylcellulose oder anor- ganische Verdickungsmittel, z.B. Aluminiumsilikate wie beispielsweise Bentonite, oder ein Gemisch aus Polyethylenglykol und Polyethylen- glykolstearat oder -distearat, enthalten- Das Verdickungsmittel ist im Gel z.B. in einer Menge zwischen 0,1 und 30 Gew.-%, bevorzugt zwischen 0,5 und 15 Gew.-%, enthalten. Cosmetic and dermatological preparations according to the invention can be present as gels which, in addition to at least one compound according to the invention and solvents usually used therefor, also include organic thickening agents, for example gum arabic, xanthan gum, sodium alginate, cellulose derivatives, preferably methyl cellulose, hydroxymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropyl methyl cellulose or inorganic Thickeners, for example aluminum silicates such as bentonites, or a mixture of polyethylene glycol and polyethylene glycol stearate or distearate, are contained. The thickener is in the gel, for example, in an amount between 0.1 and 30% by weight, preferably between 0.5 and 15 % By weight.
Erfindungsgemäße Zubereitungen können in Form fester Stifte vorliegen und enthalten dann z.B. natürliche oder synthetische Wachse, Fettalkohole oder Fetfsäureester. Bevorzugt werden Lippenpflegestifte sowie desodorierende Stifte ("Deo-Sticks").Preparations according to the invention may be in the form of solid sticks and then contain e.g. natural or synthetic waxes, fatty alcohols or fatty acid esters. Lip care sticks and deodorant sticks ("deodorant sticks") are preferred.
Als Treibmittel für erfindungsgemäße, aus Aerosolbehaltern versprühbare erfindungsgemaße kosmetische oder dermatologische Zubereitungen sind die üblichen bekannten leichtflüchtigen, verflüssigten Treibmittel, z.B. Kohlenwasserstoffe (Propan, Butan, Isobutan) geeignet, die allein oder in Mischung miteinander eingesetzt werden können- Auch Druckluft ist vorteilhaft zu verwenden.Suitable blowing agents for cosmetic or dermatological preparations according to the invention which can be sprayed from aerosol containers are the customary known volatile, liquefied blowing agents, e.g. Hydrocarbons (propane, butane, isobutane) are suitable, which can be used alone or in a mixture with one another. Compressed air can also be used advantageously.
Es ist oft vorteilhaft, erfindungsgemäße Zubereitungen abzupuffern. Vorteilhaft ist ein pH-Bereich von 3,5 - 7,5. Besonders günstig ist es, den pH-Wert in einem Bereich von 4,0 - 6,5 zu wählen.It is often advantageous to buffer preparations according to the invention. A pH range of 3.5 - 7.5 is advantageous. It is particularly favorable to choose the pH in a range from 4.0 to 6.5.
Die erfindungsgemäßen kosmetischen, mundhygienischen und/oder dermatologischen Zubereitungen können zur Behandlung der Haut, der Haare sowie Zähne und Mundschleimhaut im Sinne einer dermatologischen Behandlung oder einer Behandlung im Sinne der pflegenden Kosmetik dienen. Sie können aber auch in Schminkprodukten in der dekorativen Kosmetik oder in der Mundhygiene eingesetzt werden-The cosmetic, oral hygiene and / or dermatological preparations according to the invention can be used to treat the skin, hair, teeth and oral mucosa in the sense of dermatological treatment or treatment in the sense of nourishing cosmetics. But they can also be used in make-up products in decorative cosmetics or in oral hygiene.
Zur Anwendung werden die erfindungsgemäßen kosmetischen, mundhygienischen und/oder dermatologischen Formulierungen in der für Kosmetika und Dermatika üblichen Weise auf die Haut, auf die Zähne, das Zahnfleisch sowie die Mundschleimhaut und Zunge und/oder die Haare in ausreichender Menge aufgebracht.For use, the cosmetic, oral hygiene and / or dermatological formulations according to the invention are applied in a sufficient amount to the skin, teeth, gums and oral mucosa and tongue and / or hair in the manner customary for cosmetics and dermatics.
Unter Mundhygieneprodukten (mundhygienischen Zubereitungen) werden in der vorliegenden Erfindung die dem Fachmann geläufigen Formulierungen zur Reinigung und Pflege der Mundhöhle und des Oral hygiene products (oral hygiene preparations) in the present invention include the formulations familiar to the person skilled in the art for cleaning and maintaining the oral cavity and the
Rachenraumes sowie zur Erfrischung des Atems verstanden- Bekannte und gebräuchliche mundhygienische Formulierungen sind sowohl Cremes, Gele, Pasten, Schäume, Emulsionen, Suspensionen, Areosole, Sprays als auch Kapseln, Granulate, Pastillen, Tabletten, Bonbons oder s Kaugummis, ohne dass diese Aufzählung an Darreichungsformen bzgl- der Einsatzmöglichkeiten limitierend ist. Solche Formulierungen dienen dazu, Zahnsubstanz und Mundhöhle zu reinigen und zu pflegen sowie den Atem zu erfrischen. Werden die erfindungsgemäß zu verwendenden sekundären Alkohole 10 der Formel (I) in Deodorantien eingearbeitet, so können diese Deodorantien beispielsweise flüssig als Aerosol-Spray, Pump-Spray, Gel, Roll-on und dergleichen oder auch als feste Zubereitung wie beispielsweise als Stift oder Puder vorliegen. Ebenfalls vorteilhaft sind solche kosmetischen und/oder dermale tologischen Zubereitungen, die in der Form eines Sonnenschutzmittels vorliegen. Vorteilhaft enthalten diese zusätzlich mindestens einen UVA- Filter und/oder mindestens einen UVB-Filter und/oder mindestens ein anorganisches Pigment- Bei erfindungsgemäßen Zubereitungen zur Behandlung der Haare han- 20 delt es sich beispielsweise um Shampoonierungsmittel, Zubereitungen, die beim Spülen der Haare vor oder nach der Shampoonierung, vor oder nach der Dauerwellbehandlung, vor oder nach der Färbung oder Entfärbung der Haare angewendet werden, um Zubereitungen zum Fönen oder Einlegen der Haare, Zubereitungen zum Färben oder 25 Entfärben, um eine Frisier- und Behandlungslotion, einen Haarlack oder um Dauerwellmittel. In einer bevorzugte Ausführungsform handelt es sich bei den Zubereitungen um Mittel gegen Kopfschuppen, wie beispielsweise Antischuppenshampoos. Throat cavity and breath freshening understood - Known and common oral hygiene formulations are creams, gels, pastes, foams, emulsions, suspensions, areosols, sprays as well as capsules, granules, lozenges, tablets, candies or chewing gums, without this list Dosage forms are limiting with regard to the possible uses. Such formulations serve to clean and care for tooth substance and oral cavity and to refresh the breath. If the secondary alcohols 10 of the formula (I) to be used according to the invention are incorporated into deodorants, these deodorants can be, for example, liquid as an aerosol spray, pump spray, gel, roll-on and the like or as a solid preparation, for example as a stick or powder available. Cosmetic and / or dermal tological preparations which are in the form of a sunscreen are also advantageous. These advantageously additionally contain at least one UVA filter and / or at least one UVB filter and / or at least one inorganic pigment. Preparations according to the invention for treating the hair are, for example, shampooing agents, preparations which are used when the hair is rinsed or after the shampooing, before or after the permanent wave treatment, before or after the coloring or decolorization of the hair, for preparations for blow-drying or inlaying the hair, preparations for coloring or decoloring, for a hairdressing and treatment lotion, a hair lacquer or around permanent wave products. In a preferred embodiment, the preparations are anti-dandruff agents, such as anti-dandruff shampoos.
Erfindungsgemäße kosmetische Zubereitungen, die ein Shampoonierungsmittel oder eine Wasch-, Dusch- oder Badezubereitung darstellen, enthalten vorzugsweise mindestens eine anionische, nicht-ionische oder amphotere oberflächenaktive Substanz oder Gemische daraus-Cosmetic preparations according to the invention which are a shampooing agent or a washing, showering or bathing preparation preferably contain at least one anionic, nonionic or amphoteric surface-active substance or mixtures thereof.
Liegt eine erfindungsgemäße kosmetische oder dermatologische Zubereitung in Form einer Lotion vor, die ausgespült und z.B. vor oder nach der Entfärbung, vor oder nach der Shampoonierung, zwischen zwei Shampoonierungsschritten, vor oder nach der Dauerwell- behandiung angewendet wird, so handelt es sich dabei z.B. um wäss- rige oder wässrig-alkoholische Lösungen, die gegebenenfalls oberflächenaktive Substanzen enthalten, bevorzugt nicht-ionische oder kationische oberflächenaktive Substanzen, deren Konzentration zwischen 0,1 und 10 Gew.-%, vorzugsweise zwischen 0,2 und 5 Gew.- %, liegen kann. Diese kosmetische oder dermatologische Zubereitung kann auch ein Aerosol mit den üblicherweise dafür verwendeten Hilfsmitteln darstellen.Is there a cosmetic or dermatological preparation according to the invention in the form of a lotion which is rinsed out and e.g. before or after decolorization, before or after shampooing, between two shampooing steps, before or after permanent wave treatment, these are e.g. aqueous or aqueous-alcoholic solutions, which may contain surface-active substances, preferably non-ionic or cationic surface-active substances, the concentration of which is between 0.1 and 10% by weight, preferably between 0.2 and 5% by weight, can lie. This cosmetic or dermatological preparation can also be an aerosol with the auxiliaries usually used for it.
Eine erfindungsgemaße kosmetische Zubereitung in Form einer Lotion, die nicht ausgespült wird, insbesondere eine Lotion zum Einlegen der Haare, eine Lotion, die beim Fönen der Haare verwendet wird, eine Frisier- und Behandlungslotion, stellt im allgemeinen eine wässrige, alkoholische oder wässrig-alkoholische Lösung dar und enthält mindestens ein kationisches, anionisches, nicht-ionisches oder amphoteres Polymer oder auch Gemische derselben. Erfindungsgemäße kosmetische und dermatologische Zubereitungen zur Behandlung und Pflege der Haare können als Emulsionen vorliegen, die vom nicht-ionischen oder anionischen Typ sind. Nicht-ionische Emulsionen enthalten dabei neben Wasser Öle oder Fettalkohole, die beispielsweise polyethoxyliert oder polypropoxyliert sein können, oder auch Gemische aus den beiden organischen Komponenten. Diese Emul- A cosmetic preparation according to the invention in the form of a lotion that is not rinsed out, in particular a lotion for inlaying the hair, a lotion that is used for blow-drying the hair, a styling and treatment lotion, is generally an aqueous, alcoholic or aqueous-alcoholic Solution and contains at least one cationic, anionic, non-ionic or amphoteric polymer or mixtures thereof. Cosmetic and dermatological preparations according to the invention for the treatment and care of the hair can be present as emulsions which are of the non-ionic or anionic type. In addition to water, non-ionic emulsions contain oils or fatty alcohols, which can be polyethoxylated or polypropoxylated, for example, or also mixtures of the two organic components. This emul
sionen enthalten gegebenenfalls kationische oberflächenaktive Substanzen. Anionische Emulsionen sind vorzugsweise vom Typ einer Seife und enthalten mindestens eine erfindungsgemäße ethoxylierte oder propoxylierte organische Verbindung mit anionischem oder nicht- ionischem Charakter-Sions may contain cationic surface-active substances. Anionic emulsions are preferably of the soap type and contain at least one ethoxylated or propoxylated organic compound according to the invention with an anionic or non-ionic character.
Die folgenden Beispiele sollen die Verkörperungen der vorliegenden Erfindungen verdeutlichen. Prozentangaben beziehen sich stets auf Gewichtsprozent, sofern nicht andere Angaben gemacht werden. . Herstellung sekundärer Alkohole der Formel I: 1.1 -(Alkylphenyl)-butan-2-o!e:The following examples are intended to illustrate the embodiments of the present invention. Percentages always refer to percentages by weight, unless other information is given. , Preparation of secondary alcohols of the formula I: 1.1 - (alkylphenyl) butan-2-o! E:
Allgemeine Vorschrift:General rule:
In einem 2-I Rührkolben werden 290,4 g (5 mol) Aceton, 330 g Wasser und 13,3 g (0,33 mol) Natriumhydroxid vorgelegt. Der aromatische Aldehyd (2,5 mol) wird in 100 g Aceton gelöst und in 1h dosiert. Nach 90-minütigem Nachrühren bei 25°C wird Eissessig neutralisiert und das überschüssige Aceton bei Normaldruck abdestilliert. Der Rückstand wird 2mal mit 200 ml Toluol extrahiert. Die Organische Phase wird abgetrennt und mit Wasser gewaschen. Der nach Abdestillieren des Toluols verbleibende Rückstand wird zur Isolierung des 4-(Alkylphenyl)- 3-buten-2-ons destilliert- 1 mol des erhaltenen 4-(Alkylphenyl)-3-buten- 2-on wird in 300 ml Ethanol in Gegenwart von 3 Gew.-% Raney Nickel bei einer Temperatur von 20-40°C und einem Wasserstoffdruck von 10 bis 20 bar hydriert- Nach Aufnahme der theoretisch berechneten Wasserstoffmenge wird die Hydrierung abgebrochen, der Katalysator abfiltriert und der Ansatz vom Lösungsmittel befreit. Das als Rückstand erhaltene 4~(Alkylphenyl)butan-2-ol wird destillativ gereinigt.290.4 g (5 mol) of acetone, 330 g of water and 13.3 g (0.33 mol) of sodium hydroxide are placed in a 2 l stirred flask. The aromatic aldehyde (2.5 mol) is dissolved in 100 g of acetone and metered in in 1 hour. After stirring for a further 90 minutes at 25 ° C., glacial acetic acid is neutralized and the excess acetone is distilled off at normal pressure. The residue is extracted twice with 200 ml of toluene. The organic phase is separated off and washed with water. The residue remaining after distilling off the toluene is distilled to isolate the 4- (alkylphenyl) -3-buten-2-one. 1 mol of the 4- (alkylphenyl) -3-buten-2-one obtained is in 300 ml of ethanol in the presence of 3% by weight of Raney nickel hydrogenated at a temperature of 20-40 ° C. and a hydrogen pressure of 10 to 20 bar. After the theoretically calculated amount of hydrogen has been taken up, the hydrogenation is terminated, the catalyst is filtered off and the batch is freed from the solvent. The 4 ~ (alkylphenyl) butan-2-ol obtained as a residue is purified by distillation.
1.2. 4-(Alkylphenyl)-3-methyl-butan-2-o!e 1.2. 4- (alkylphenyl) -3-methyl-butan-2-o e!
Allgemeine Vorschrift: In einem 2-1 Rührkolben werden 433 g (6 mol) Methylethylketon sowie 1 ,5 mol des aromatischen Aldehyds vorgelegt und auf 60°C erwärmt. Innerhalb von 1.5h werden 100g 50%iger Schwefelsäure zudosiert- Nach 4-6h Nachrühren bei 60-65°C wird abgekühlt, mit Natriumbicarbonat- Lösung neutralisiert und das überschüssige Methylethylketon bei Normaldruck abdestilliert- Der Rückstand wird zweimal mit 200 ml Toluol extrahiert. Die organische Phase wird abgetrennt und mit Wasser gewaschen- Der nach Abdestillieren des Toluols verbleibende Rückstand wird zur Isolierung des 4-(Alkylphenyl)- 3-methyl-buten-2-ons destilliert- 1 mol des erhaltenen 4-(Alkylphenyl)-3- buten-2-on wird in 300 ml Ethanol in Gegenwart von 3 Gew.-% Raney Nickel bei einer Temperatur von 180°C und einem Wasserstoffdruck von 10 bis 20 bar hydriert. Nach Aufnahme der theoretisch berechneten Wasserstoffmenge wird die Hydrierung abgebrochen, der Katalysator abfiltriert und der Ansatz vom Lösungsmittel befreit. Das als Rückstand erhaltene 4-(Alkylphenyl)butan-2-ol wird destillativ gereinigt. Auf diese Weise wurden beispielsweise erhalten: a) 4-(2,4,5-Trimethylphenyl)-2-butanol aus 2,4,5-TrimethyIbenzaldehyd:General instructions: 433 g (6 mol) of methyl ethyl ketone and 1.5 mol of the aromatic aldehyde are placed in a 2-1 stirred flask and heated to 60.degree. 100 g of 50% strength sulfuric acid are metered in over a period of 1.5 hours. After stirring for 4-6 hours at 60-65 ° C., the mixture is cooled, neutralized with sodium bicarbonate solution and the excess methyl ethyl ketone is distilled off under normal pressure. The residue is extracted twice with 200 ml of toluene. The organic phase is separated off and washed with water. The residue which remains after the toluene has been distilled off is distilled to isolate the 4- (alkylphenyl) -3-methyl-buten-2-one - 1 mol of the 4- (alkylphenyl) -3- obtained. buten-2-one is hydrogenated in 300 ml of ethanol in the presence of 3% by weight of Raney nickel at a temperature of 180 ° C. and a hydrogen pressure of 10 to 20 bar. After the theoretically calculated amount of hydrogen has been taken up, the hydrogenation is terminated, the catalyst is filtered off and the batch is freed from the solvent. The 4- (alkylphenyl) butan-2-ol obtained as a residue is purified by distillation. In this way, for example, the following were obtained: a) 4- (2,4,5-trimethylphenyl) -2-butanol from 2,4,5-trimethylbenzaldehyde:
1H NMR (200 MHz; CDCI3, δ ppm): 1.24 (d, J = 6,2 Hz, 3H), 1.62-1.75 (m, 2H), 2,19 (s, 6H), 2.25 (s, 3H), 2.50-2.76 (m, 2H), 3.77 (sext-, J = 6,2 Hz, 1H), 6.91 (s, 2H). 13C NMR (200 MHz; CDCI3, δ ppm): 18-6, 19.10, 19-18, 23-56, 29.03, 39.90, 67-83, 130-11, 131.51, 132.85, 133.74, 25 133.79, 137.33. Geruch: Sehr geringe Intensität; leicht Reseda-artig nach Styrolylalkoho b) 3-Methyl-4-(2-methylphenyl)-2-butanol aus 2-MethyIbenzaldehyd: 1 H NMR (200 MHz; CDCI 3 , δ ppm): 1.24 (d, J = 6.2 Hz, 3H), 1.62-1.75 (m, 2H), 2.19 (s, 6H), 2.25 (s, 3H), 2.50-2.76 (m, 2H), 3.77 (sext-, J = 6.2 Hz, 1H), 6.91 (s, 2H). 13 C NMR (200 MHz; CDCI 3 , δ ppm): 18-6, 19.10, 19-18, 23-56, 29.03, 39.90, 67-83, 130-11, 131.51, 132.85, 133.74, 25 133.79, 137.33 , Odor: very low intensity; slightly reseda-like after styrolyl alcohol b) 3-methyl-4- (2-methylphenyl) -2-butanol from 2-methylbenzaldehyde:
1H NMR (200 MHz; CDCI3, δ ppm, Isomerengemisch 1,4:1): 0.88 (d, J = 6,77 Hz, 3H), 1.21 (d, J = 6,38 Hz, 3H), 1.34 (d, J = 5,27 Hz, 1H), 1.70- 1.88 (m, 1H), 2.29 (dd, J = 13,5 Hz, J = 9,74 Hz, 1H), 2.32 (s, 3H), 2.83 (dd, J = 13,5 Hz, J = 5,7 Hz, 1H), 3.71-3.85 (m, 1H), 7.10-7.14 (m, 4H). 3C NMR (200 MHz; CDCI3, δ ppm, Isomerengemisch 1,4:1): 13.59, 19.47, 19.56, 36.30, 40.27, 70.41, 125.77, 129.94, 130.12 (2C), 136.14, 139.16. 1 H NMR (200 MHz; CDCI 3 , δ ppm, mixture of isomers 1.4: 1): 0.88 (d, J = 6.77 Hz, 3H), 1.21 (d, J = 6.38 Hz, 3H), 1.34 (d, J = 5.27 Hz, 1H), 1.70-1.88 (m, 1H), 2.29 (dd, J = 13.5 Hz, J = 9.74 Hz, 1H), 2.32 (s, 3H), 2.83 (dd, J = 13.5 Hz, J = 5.7 Hz, 1H), 3.71-3.85 (m, 1H), 7.10-7.14 (m, 4H). 3 C NMR (200 MHz; CDCI 3 , δ ppm, mixture of isomers 1.4: 1): 13.59, 19.47, 19.56, 36.30, 40.27, 70.41, 125.77, 129.94, 130.12 (2C), 136.14, 139.16.
Geruch: Fast geruchlos, leicht citrischSmell: Almost odorless, slightly citrusy
c) 4-(4-lsopropylphenyl)-3-methyl-2-butanol aus 4-lsoprapylbenzaIdehyd:c) 4- (4-isopropylphenyl) -3-methyl-2-butanol from 4-isoprapylbenzaldehyde:
1H NMR (200 MHz; CDCI3, δ ppm, Isomerengemisch 1,3:1): 0.86 (d, J = 6,84 Hz, 3H), 1.21 (d, J = 6,39 Hz, 3H), 1.24 (d, J = 6.92 Hz, 6H), 1.70- 1.88 (m, 1 H), 2.32 (dd, J = 13,4 Hz, J = 9,3 Hz, 1 H), 2,77 (hept., J = 6,98 Hz, 1H), 2.82 (dd, J = 13,4 Hz, J = 5,92 Hz, 1H), 3.62-3.92 (m, 1H), 7.0-7.20 (m, 4H). 13C NMR (200 MHz; CDCI3, δ ppm, Isomerengemisch 1,3:1): 13.62, 20.39, 24.04 (2C), 33.61, 38.79, 41.68, 70.21, 126.11, 126.13, 128.90 (2C), 138.27, 146.06. 1 H NMR (200 MHz; CDCI 3 , δ ppm, mixture of isomers 1.3: 1): 0.86 (d, J = 6.84 Hz, 3H), 1.21 (d, J = 6.39 Hz, 3H), 1.24 (d, J = 6.92 Hz, 6H), 1.70-1.88 (m, 1 H), 2.32 (dd, J = 13.4 Hz, J = 9.3 Hz, 1 H), 2.77 (hept., J = 6.98 Hz, 1H), 2.82 (dd, J = 13.4 Hz, J = 5.92 Hz, 1H), 3.62-3.92 (m, 1H), 7.0-7.20 (m, 4H). 13 C NMR (200 MHz; CDCI 3 , δ ppm, mixture of isomers 1.3: 1): 13.62, 20.39, 24.04 (2C), 33.61, 38.79, 41.68, 70.21, 126.11, 126.13, 128.90 (2C), 138.27, 146.06 ,
Geruch: Fast geruchlos, leicht wäßrig-citrischOdor: Almost odorless, slightly watery-citric
d) 4-(4-lsobutylphenyl)-3-methyl-2-butanoI aus 4-lsobutylbenzaldehyd:d) 4- (4-isobutylphenyl) -3-methyl-2-butanol from 4-isobutylbenzaldehyde:
1H NMR (200 MHz; CDCI3, δ ppm, Isomerengemisch 1,07:1): 0.86 (d, J 1 H NMR (200 MHz; CDCI 3 , δ ppm, mixture of isomers 1.07: 1): 0.86 (d, J
= 6,81 Hz, 3H), 0.89 (d, J = 6.6 Hz, 6H), 1.21 (d, J = 6,31 Hz, 3H), 1.70- 1.88 (m, 1H), 1.70-1.95 (m, 1H), 2.32 (dd, J = 13,4 Hz, J = 9,3 Hz, 1H),= 6.81 Hz, 3H), 0.89 (d, J = 6.6 Hz, 6H), 1.21 (d, J = 6.31 Hz, 3H), 1.70-1.88 (m, 1H), 1.70-1.95 (m, 1H), 2.32 (dd, J = 13.4 Hz, J = 9.3 Hz, 1H),
2.44 (d, J = 7,13 Hz, 2H), 2,78 (dd, J = 13.4 Hz, J = 9,4 Hz, 1H), 3.62- 2.44 (d, J = 7.13 Hz, 2H), 2.78 (dd, J = 13.4 Hz, J = 9.4 Hz, 1H), 3.62-
3.92 ( , 1H), 7.0-7.20 ( , 4H). 13C NMR (200 MHz; CDCI3, δ ppm, Isomerengemisch 1,07:1): 13.56, 20.46, 22.36 (2C), 30.21, 38.88, 41.71, 44.99, 70.28, 128.70, 128.85, 128.86 (2C), 138.10, 138.95. Geruch: Schwach rosig, citrisch e) 3-MethyI-4-(2,4,5-trimethylphenyl)-2-butanoI aus 2,4,5- Trimethylbenzaldehyd:3.92 (.1H), 7.0-7.20 (.4H). 13 C NMR (200 MHz; CDCI 3 , δ ppm, mixture of isomers 1.07: 1): 13.56, 20.46, 22.36 (2C), 30.21, 38.88, 41.71, 44.99, 70.28, 128.70, 128.85, 128.86 (2C), 138.10 , 138.95. Odor: slightly rosy, citric e) 3-methyl-4- (2,4,5-trimethylphenyl) -2-butanoI from 2,4,5-trimethylbenzaldehyde:
Η NMR (200 MHz; CDCI3, δ ppm, Isomerengemisch 1,1:1): 0.87 (d, J = 10 6,8 Hz, 3H), 1.22 (d, J = 6,3 Hz, 3H), 1.66-1.88 (m, 1H), 2.20 (s, 9H), 2.2-2.3 (m, 1H), 2.6-2.8 (m, 1H), 3.70-3.82 (m, 1H), 6.8 (s, 1H), 6.9 (s, 1H). 13C NMR (200 MHz; CDCI3, δ ppm, Isomerengemisch 1,1:1): 14.64, 18.91, 19.19 (2C), 19.64, 35.84, 41.16, 71.77, 131.22, 131.52, 133.29, 133.38, 133.72, 136.37.Η NMR (200 MHz; CDCI 3 , δ ppm, mixture of isomers 1.1: 1): 0.87 (d, J = 10 6.8 Hz, 3H), 1.22 (d, J = 6.3 Hz, 3H), 1.66 -1.88 (m, 1H), 2.20 (s, 9H), 2.2-2.3 (m, 1H), 2.6-2.8 (m, 1H), 3.70-3.82 (m, 1H), 6.8 (s, 1H), 6.9 (s, 1H). 13 C NMR (200 MHz; CDCI 3 , δ ppm, mixture of isomers 1.1: 1): 14.64, 18.91, 19.19 (2C), 19.64, 35.84, 41.16, 71.77, 131.22, 131.52, 133.29, 133.38, 133.72, 136.37.
15 Geruch: Fast geruchlos, leicht blumig, zimartig f) 3-Methyl-4-(2,4,6-trimethylphenyl)-2-butanol aus 2,4,6- Trimethylbenzaldehyd:15 Odor: almost odorless, slightly flowery, cinnamon-like f) 3-methyl-4- (2,4,6-trimethylphenyl) -2-butanol from 2,4,6-trimethylbenzaldehyde:
20 H NMR (200 MHz; CDCI3, δ ppm, Isomerengemisch 1,1 :1): 0.86 (d, J = 6,9 Hz, 3H), 1.25 (d, J = 6,3 Hz, 3H), 1.70-1.90 (m, 1H), 2,24 (s, 3H), 2.29 (s, 6H), 2.42 (dd, J = 13.6 Hz, J = 9,7 Hz, 1H), 2.8 (dd, J = 13,6 Hz, J = 9,7 Hz, 1H),3.70-3.82 (m, 1H), 6.8 (s, 2H). 13C NMR (200 MHz; CDCI3, δ ppm, Isomerengemisch 1,1:1): 14.60, 20.34, 20.41 (2C), 20.75,20 H NMR (200 MHz; CDCI 3 , δ ppm, mixture of isomers 1.1: 1): 0.86 (d, J = 6.9 Hz, 3H), 1.25 (d, J = 6.3 Hz, 3H), 1.70 -1.90 (m, 1H), 2.24 (s, 3H), 2.29 (s, 6H), 2.42 (dd, J = 13.6 Hz, J = 9.7 Hz, 1H), 2.8 (dd, J = 13 , 6 Hz, J = 9.7 Hz, 1H), 3.70-3.82 (m, 1H), 6.8 (s, 2H). 13 C NMR (200 MHz; CDCI 3 , δ ppm, mixture of isomers 1.1: 1): 14.60, 20.34, 20.41 (2C), 20.75,
25 31.57, 40.81, 72.33, 128.85, 128.94, 134.78, 134.84, 136.47, 136.59. 25 31.57, 40.81, 72.33, 128.85, 128.94, 134.78, 134.84, 136.47, 136.59.
Geruch: Leicht schwach frisch, Selleri g) 4-(3,4-Dimethylphenyl)-3-methyl-2-butanol aus 3,4- DimethylbenzaldehydOdor: slightly weakly fresh, celery 4- (3,4-dimethylphenyl) -3-methyl-2-butanol from 3,4-dimethylbenzaldehyde
1H NMR (200 MHz; CDCI3, δ ppm, Isomerengemisch 1,1:1): 0.86 (d, J = 6,8 Hz, 3H), 1.19 (d, J = 6,41 Hz, 3H), 1.70-1.86 (m, 1H), 2.23 (s, 6H), 2.33 (dd, J = 13,3 Hz, J = 8,8 Hz, 1H), 2.72-2.80 (m, 1H), 3,66-3.76 (m, 1H), 6.7-7.1 (m, 3H). 13C NMR (200 MHz; CDCI3, δ ppm, Isomerengemisch 1,1:1): 14.56, 19.27, 19.73, 20.36, 38.73, 41.73, 70.25, 126.38, 129.35, 130.34, 133.66, 136.13, 138.26. 1 H NMR (200 MHz; CDCI 3 , δ ppm, mixture of isomers 1.1: 1): 0.86 (d, J = 6.8 Hz, 3H), 1.19 (d, J = 6.41 Hz, 3H), 1.70 -1.86 (m, 1H), 2.23 (s, 6H), 2.33 (dd, J = 13.3 Hz, J = 8.8 Hz, 1H), 2.72-2.80 (m, 1H), 3.66-3.76 (m, 1H), 6.7-7.1 (m, 3H). 13 C NMR (200 MHz; CDCI 3 , δ ppm, mixture of isomers 1.1: 1): 14.56, 19.27, 19.73, 20.36, 38.73, 41.73, 70.25, 126.38, 129.35, 130.34, 133.66, 136.13, 138.26.
Geruch: Leicht Rosig, etwas lactonig h) 4-(3,4-Dimethylphenyl)-2-butanol aus 3,4-DimethylbenzaldehydOdor: Slightly rosy, somewhat lactonic h) 4- (3,4-dimethylphenyl) -2-butanol from 3,4-dimethylbenzaldehyde
1H NMR (200 MHz; CDCI3, δ ppm) : 1.22 (d, J = 6,1 Hz, 3H), 1.68-1.80 ( , 2H), 2.22 (s, 3H), 2.23 (s, 3H), 2.45-2.80 (m, 2H), 3.82 (sext. J = 6,1 Hz, 1H), 6.90-7.10 (m, 3H). 3C NMR (200 MHz; CDCI3, δ ppm) : 19.26, 19.72, 23.48, 31.61, 40.95, 67.43, 125.58, 129.50, 129.62, 133.72, 136.31, 139.33 1 H NMR (200 MHz; CDCI 3 , δ ppm): 1.22 (d, J = 6.1 Hz, 3H), 1.68-1.80 (, 2H), 2.22 (s, 3H), 2.23 (s, 3H), 2.45-2.80 (m, 2H), 3.82 (sext. J = 6.1 Hz, 1H), 6.90-7.10 (m, 3H). 3 C NMR (200 MHz; CDCI 3 , δ ppm): 19.26, 19.72, 23.48, 31.61, 40.95, 67.43, 125.58, 129.50, 129.62, 133.72, 136.31, 139.33
Geruch: Geruchlos i) 4-(2,4-Dimethylphenyi)-3-methyl-2-butanol aus 2,4-Odor: Odorless i) 4- (2,4-Dimethylphenyi) -3-methyl-2-butanol from 2,4-
Dimethylbenzaldehyddimethylbenzaldehyde
1H NMR (200 MHz; CDCI3, δ ppm, Isomerengemisch 1,1:1): 0.87 (d, J = 1 H NMR (200 MHz; CDCI 3 , δ ppm, mixture of isomers 1.1: 1): 0.87 (d, J =
6,5 Hz, 3H), 1.22 (d, J = 6,3 Hz, 3H), 1.70-1.86 (m, 1H), 2.28 (s, 6H),6.5 Hz, 3H), 1.22 (d, J = 6.3 Hz, 3H), 1.70-1.86 (m, 1H), 2.28 (s, 6H),
2.36 (dd, J = 13,4 Hz, J = 8,9 Hz, 1H), 2.86 (dd, J = 13,5 Hz, J = 8,9 Hz, 1H), 3,66-3.82 (m, 1H), 6.7-7.06 (m, 3H). 13C NMR (200 MHz; CDCI3, δ 2.36 (dd, J = 13.4 Hz, J = 8.9 Hz, 1H), 2.86 (dd, J = 13.5 Hz, J = 8.9 Hz, 1H), 3.66-3.82 (m, 1H), 6.7-7.06 (m, 3H). 13 C NMR (200 MHz; CDCI3, δ
ppm, Isomerengemisch 1,1:1): 14.57, 19.44, 19.64, 20.86, 35.87, 40.97, 71.74, 126.19, 129.81, 130.95, 135.18, 136.00, 138.02.ppm, mixture of isomers 1.1: 1): 14.57, 19.44, 19.64, 20.86, 35.87, 40.97, 71.74, 126.19, 129.81, 130.95, 135.18, 136.00, 138.02.
Geruch: Fast geruchlos, uncharakteristisch j) 4-(2,4-Dimethylphenyl)-2-butanol aus 2,4-DimethylbenzaldehydOdor: almost odorless, uncharacteristic j) 4- (2,4-dimethylphenyl) -2-butanol from 2,4-dimethylbenzaldehyde
1H NMR (200 MHz; CDCI3, δ ppm) : 1.24 (d, J = 6,2 Hz, 3H), 1.65-1.75 (m, 2H), 2.28 (s, 6H), 2.45-2.80 (m, 2H), 3.86 (sext. J = 6,1 Hz), 6.90- 7.10 ( , 3H). 13C NMR (200 MHz; CDCl3, δ ppm) : 19.16, 20.85, 23.53, 29.03, 39.69, 67.68, 126.48, 128.58, 130.89, 135.19, 135.54, 137.02. Geruch: Fast geruchlos, uncharakteristisch 1 H NMR (200 MHz; CDCI 3 , δ ppm): 1.24 (d, J = 6.2 Hz, 3H), 1.65-1.75 (m, 2H), 2.28 (s, 6H), 2.45-2.80 (m, 2H), 3.86 (sext. J = 6.1 Hz), 6.90-7.10 (, 3H). 13 C NMR (200 MHz; CDCl 3 , δ ppm): 19.16, 20.85, 23.53, 29.03, 39.69, 67.68, 126.48, 128.58, 130.89, 135.19, 135.54, 137.02. Smell: Almost odorless, uncharacteristic
2. WIHK-Werte2. WIHK values
2.1 Bestimmung der minimalen Hemmkonzentration2.1 Determination of the minimum inhibitory concentration
Die minimale Hemmkonzentration (MHK) der beanspruchten Substanzen wurde im Reihenverdüπnungstest (H. Brandis, G. Pulverer: Lehrbuch der Medizinischen Mikrobiologie. 6. Neubearbeitete Auflage, Gustav Fischer Verlag Stuttgart, 1988; Seite 200ff.) gegen verschiedene kosmetisch relevante Keime bestimmt. Der Test wurde auf das Mikrotiterpiattenformat übertragen und als MHK-Wert die Konzentration bestimmt, bei der nach 16 Stunden Inkubation bei der Wellenlänge von 620 nm kein signifikanter Anstieg der Trübung gegenüber den Kontrollen beobachtet wurde.The minimum inhibitory concentration (MIC) of the claimed substances was determined in the serial dilution test (H. Brandis, G. Pulverer: Textbook of Medical Microbiology. 6th revised edition, Gustav Fischer Verlag Stuttgart, 1988; page 200ff.) Against various cosmetically relevant germs. The test was transferred to the microtiter plate format and the MIC value was used to determine the concentration at which no significant increase in turbidity compared to the controls was observed after 16 hours of incubation at the wavelength of 620 nm.
Die Ergebnisse sind in Tabelle 2 dargestellt.The results are shown in Table 2.
Tabelle 2: Table 2:
Figure imgf000034_0001
Figure imgf000034_0001
2.2 In-vitro Test zur Mundgeruchsreduktion2.2 In-vitro test for bad breath reduction
Der Test beruht auf der Arbeit von Goldberg und Rosenberg (Production of Oral Malodor in an in vitro System, S. Goldberg and . Rosenberg, pp.143 - 150, in: Bad Breath- A multidisciplinary Approach, Eds: D. van Steenberghe, M. Rosenberg, Leuven University Press, 1996) und wurde zur besseren Reproduzierbarkeit angepaßt.The test is based on the work of Goldberg and Rosenberg (Production of Oral Malodor in an in vitro System, S. Goldberg and. Rosenberg, pp.143 - 150, in: Bad Breath- A multidisciplinary Approach, Eds: D. van Steenberghe, M. Rosenberg, Leuven University Press, 1996) and was adapted for better reproducibility.
Ein steriles Flüssigmedium, das mit frischem Morgenspeichel angeimpft wird, wird für einige Tage bei 37 "C in einer Coy-Box bebrütet und anschließend von einem Prüferpanel abgerochen.A sterile liquid medium, which is inoculated with fresh morning saliva, is incubated for a few days in a Coy box at 37 "C and then smelled by an inspector panel.
Es hat sich ein intensiver, typischer Mundgeruch gebildet. Nicht angeimpfte Kontrollen haben nur einen schwachen Mediengeruch. Als Kontrolle für die Tests wurde Triclosan® in einer Konzentration von 0,05 % dazugegeben. Die angeimpften Röhrchen hatten nach der Inkubation den gleichen Geruch wie die nichtangeimpften Röhrchen.An intense, typical bad breath has developed. Controls that have not been vaccinated have only a weak smell of media. As a control for the tests, Triclosan ® was added in a concentration of 0.05%. The inoculated tubes had the same smell after incubation as the non-inoculated tubes.
Die Verwendung von typischen Aromastoffen für Oral Care Anwendungen, zeigte bei Einsatz von 0,1% Konzentrationen im Test zumeist einen sehr unangenehmen Mischgeruch, der aus der Mischung The use of typical aroma substances for oral care applications, when using 0.1% concentrations in the test, usually showed a very unpleasant mixed smell, which came from the mixture
des Mundgeruchs mit dem Aromastoff entstand- Teilweise war der Aromastoff nicht mehr wahrnehmbar, da er offenbar durch die Mikroorganismen des Speichels abgebaut wurde.of the bad breath with the aroma substance - partly the aroma substance was no longer perceptible, since it was apparently broken down by the microorganisms of the saliva.
Bei Einsatz der in Tabelle 2 beschriebenen Substanzen konnte bis zu den angegebenen minimalen Wirkkonzentrationen kein Geruch analog zu Triclosan festgestellt werden-.When using the substances described in Table 2, no odor similar to triclosan could be determined up to the specified minimum active concentrations.
Andere als antimikrobiell wirksam bekannte Aromastoffe wie Eugenol und Thymol unterdrückten bei 0,1 % Einsatzkonzentration ebenfalls die Mundgeruchsbildung, hatten aber den Nachteil des sehr deutlichen Eigengeruch.Other flavorings known to be antimicrobial, such as eugenol and thymol, also suppressed bad breath formation at 0.1% use concentration, but had the disadvantage of the very distinct intrinsic odor.
Analog zur MHK wird unter der minimalen Wirkkonzentration (MWK) im vorliegenden Falle die minmale Konzentration verslanden, bei der die Bildung von Mundgeruch gehemmt wird- Analogous to the MIC, the minimum active concentration (MWK) will silt up in the present case, at which the formation of bad breath is inhibited.
Tabelle 3:Table 3:
Figure imgf000036_0001
Figure imgf000036_0001
3. Formulierungsbeispiele3. Formulation examples
Beispiel 3.1 W/O-CremeExample 3.1 W / O cream
Paraffinöl 10,00 10,00 10,00Paraffin oil 10.00 10.00 10.00
Ozokerit 4,00 4,00 4,00Ozokerite 4.00 4.00 4.00
Vaseline 4,00 4,00 4,00 pflanzliches Öl 10,00 10,00 10,00Vaseline 4.00 4.00 4.00 vegetable oil 10.00 10.00 10.00
Wollwachsalkohol 2,00 2,00 2,00Wool wax alcohol 2.00 2.00 2.00
Aluminiumstearat 0,40 0,40 0,40Aluminum stearate 0.40 0.40 0.40
4-(4-lsopropylphenyl)-3 -methyl-2- 1,00 - - butanol4- (4-isopropylphenyl) -3-methyl-2- 1.00 - - butanol
4-(2,4,5-Trimethylphβnyl)-2-butanol 1,004- (2,4,5-Trimethylphβnyl) -2-butanol 1.00
3-Methyl-4-(2,4,6-trimethylphenyl)-2- 1,00 butanol3-methyl-4- (2,4,6-trimethylphenyl) -2-1.00 butanol
Parfüm, Konservierungsstoffe q.s. q.s. q.s.Perfume, preservatives q.s. q.s. q.s.
Wasser, VES ad 100,00 ad 100,00 ad 100,00 Water, VES ad 100.00 ad 100.00 ad 100.00
Beispiel 3-2 O W-LotionExample 3-2 O W Lotion
Paraffinöl 5,00 5,00 5,00Paraffin oil 5.00 5.00 5.00
Isopropylpalmitat 5,00 5,00 5,00Isopropyl palmitate 5.00 5.00 5.00
Cetylalkohol 2,00 2,00 2,00Cetyl alcohol 2.00 2.00 2.00
Bienenwachs 2,00 2,00 2,00Beeswax 2.00 2.00 2.00
Ceteareth-20 2,00 2,00 2,00Ceteareth-20 2.00 2.00 2.00
PEG-20-GIycerylstearat 1,50 1,50 1,50PEG-20 glyceryl stearate 1.50 1.50 1.50
Glycerin 3,00 3,00 3,00Glycerin 3.00 3.00 3.00
4-(4-lsobutylphenyl)-3-methyl-2-butanol 1 ,004- (4-isobutylphenyl) -3-methyl-2-butanol 1, 00
4-(4-tert.-Butylphenyl)-3-methyl-2- 1,00 butanol4- (4-tert-butylphenyl) -3-methyl-2- 1.00 butanol
3,3-Dimethyl-4(2,4,6-trimethylphenyl)-2- - 1,00 butanol3,3-dimethyl-4 (2,4,6-trimethylphenyl) -2- - 1.00 butanol
Parfüm, Konservierungsstoffe q.s. q.s. q.s. Wasser, VES ad 100,00 ad 100,00 ad 100,00 Perfume, preservatives qsqsqs water, VES ad 100.00 ad 100.00 ad 100.00
Beispiel 3-3 O W-CremeExample 3-3 O W Cream
Pflanzliches Öl 10,00 10,00 10,00Vegetable oil 10.00 10.00 10.00
Cetylalkohol 2,00 2,00 2,00Cetyl alcohol 2.00 2.00 2.00
Glycerinmonostearat 1,50 1,50 1,50Glycerol monostearate 1.50 1.50 1.50
PEG-30-Glycerylstearat 2,00 2,00 2,00PEG-30 glyceryl stearate 2.00 2.00 2.00
Glycerin 3,00 3,00 3,00Glycerin 3.00 3.00 3.00
IsopropylpalmKat 5,00 5,00 5,00Isopropyl Palm Cat 5.00 5.00 5.00
Carbopol 980 (neutralisiert) 0,30 0,30 0,30Carbopol 980 (neutralized) 0.30 0.30 0.30
4-(4-lsobutylphenyl)-3-methyl-2-butanol 1,00 - -4- (4-isobutylphenyl) -3-methyl-2-butanol 1.00 - -
4-Bicyc!o[2.2.1 ]hept-2-yi-3-methyl-2- - 1,00 - butanol4-Bicyc! O [2.2.1] hept-2-yi-3-methyl-2- - 1.00 - butanol
4-(3,4-Dimethylphenyl)-2-butanol 1,00 Parfüm, Konservierungsstoffe q.s. q.s. q.s. Wasser, VES ad 100,00 ad 100,00 ad 100,00 4- (3,4-dimethylphenyl) -2-butanol 1.00 perfume, preservatives qsqsqs water, VES ad 100.00 ad 100.00 ad 100.00
Beispiel 3-4 SalbeExample 3-4 ointment
Vaseline 36,00 36,00 36,00Vaseline 36.00 36.00 36.00
Ceresin 10,00 10,00 10,00Ceresin 10.00 10.00 10.00
Zinkoxid 4,00 4,00 4,00Zinc oxide 4.00 4.00 4.00
Pflanzliches Öl 20,00 20,00 20,00Vegetable oil 20.00 20.00 20.00
4-(2,4,5-Trimethylphenyl)-2-butanol 0,02 - -4- (2,4,5-trimethylphenyl) -2-butanol 0.02 - -
3-Methyl-(2-methylphenyl)-2-butanol - 0,02 -3-methyl- (2-methylphenyl) -2-butanol - 0.02 -
4-(4-tert.-Butylphenyl)-3-methyl-2-butanol - - 0,024- (4-tert-butylphenyl) -3-methyl-2-butanol - - 0.02
Parfüm, Konservierungsstoffe q.s. q.s. q.s.Perfume, preservatives q.s. q.s. q.s.
Paraffinöl ad 100,00 ad 100,00 ad 100,00Paraffin oil ad 100.00 ad 100.00 ad 100.00
Beispiel 3.5 HautölExample 3.5 Skin Oil
Cetylpalmitat 3,00 3,00 3,00 C12-15- Alkylbenzoat 2,00 2,00 2,00 Polyisobuten 10,00 10,00 10,00 Cetyl palmitate 3.00 3.00 C12-15 alkyl benzoate 2.00 2.00 2.00 polyisobutene 10.00 10.00 10.00
Squalan 2,00 2,00 2,00Squalane 2.00 2.00 2.00
4-(2,4,5-TrimethyIphenyl)-3-methyl-2- 0,50 butanol4- (2,4,5-trimethylphenyl) -3-methyl-2-0.50 butanol
4-(4-lsobutylphenyl)-3-methyl-2-butanoi 0,504- (4-isobutylphenyl) -3-methyl-2-butanoi 0.50
3,3-Dimethy-4-phenyl-2-butanol 0,503,3-dimethy-4-phenyl-2-butanol 0.50
Parfüm, Konservierungsstoffe q.s. q.s. q.s.Perfume, preservatives q.s. q.s. q.s.
Paraffinöl ad 100,00 ad 100,00 ad 100,00Paraffin oil ad 100.00 ad 100.00 ad 100.00
Beispiel 3.6 LippenstiftExample 3.6 Lipstick
Ceresin 8,00 8,00 8,00Ceresin 8.00 8.00 8.00
Bienenwachs 4,00 4,00 4,00Beeswax 4.00 4.00 4.00
Carnaubawachs 2,00 2,00 2,00Carnauba wax 2.00 2.00 2.00
Vaseline 40,00 40,00 40,00Vaseline 40.00 40.00 40.00
Hydriertes Rizinusöl 4,00 4,00 4,00Hydrogenated castor oil 4.00 4.00 4.00
Caprylic/Capric Triglyceride 6,00 6,00 6,00Caprylic / Capric Triglyceride 6.00 6.00 6.00
3-Methyl-4-(2,4,5-trimethyl)-2-butanol 0,023-methyl-4- (2,4,5-trimethyl) -2-butanol 0.02
5,5-Dimethyi-6-(3-methylphenyl)-2- 0,02 butanol 5,5-Dimethyi-6- (3-methylphenyl) -2-0.02 butanol
4-(4-lsobutylphenyl)-3-methyl-2-butanol - - 0,024- (4-isobutylphenyl) -3-methyl-2-butanol - - 0.02
Parfüm, Konservierungsstoffe q.s. q.s. q.s.Perfume, preservatives q.s. q.s. q.s.
Paraffinöl ad 100,00 ad 100,00 ad 100,00Paraffin oil ad 100.00 ad 100.00 ad 100.00
Beispiel 3-7 PflegemaskeExample 3-7 Care Mask
PEG-50 Lanolin 0,50 0,50 0,50PEG-50 lanolin 0.50 0.50 0.50
Glycerylstearat 2,00 2,00 2,00Glyceryl stearate 2.00 2.00 2.00
Sonnenblumenkernöl 3,00 3,00 3,00Sunflower seed oil 3.00 3.00 3.00
Bentonit 8,00 8,00 8,00Bentonite 8.00 8.00 8.00
Kaolin 35,00 35,00 35,00Kaolin 35.00 35.00 35.00
Zinkoxid 5,00 5,00 5,00Zinc oxide 5.00 5.00 5.00
3,3-Dimethyl-4-phenyl-2-butaπol 1,00 - -3,3-dimethyl-4-phenyl-2-butaπol 1.00 - -
5,5-Dimethyl-6-(3-methylphenyl)-2-hexanol - 1,00 -5,5-dimethyl-6- (3-methylphenyl) -2-hexanol - 1.00 -
3-Methyl 4-(2,4-dimethylphenyI)-2-butanol - - 1,003-methyl 4- (2,4-dimethylphenyl) -2-butanol - - 1.00
Parfüm, Konservierungsstoffe q.s. q.s. q.s.Perfume, preservatives q.s. q.s. q.s.
Wasser ad 100,00 ad 100,00 ad 100,00 Water ad 100.00 ad 100.00 ad 100.00
Beispiel 3-8Example 3-8
Duschpräparat mit RückfetterShower preparation with moisturizer
Cocoamidodiacetat 10,00 10,00 10,00Cocoamidodiacetate 10.00 10.00 10.00
Natriumlaurylsulfat 25,00 25,00 25,00Sodium lauryl sulfate 25.00 25.00 25.00
Kalium Cocyl Hydrolysiertes Kollagen 5,00 5,00 5,00Potassium Cocyl Hydrolyzed Collagen 5.00 5.00 5.00
Macadamianussöl 5,00 5,00 5,00Macadamia nut oil 5.00 5.00 5.00
Natriumchlorid 0,60 0,60 0,60Sodium chloride 0.60 0.60 0.60
3-MethyI-4-(2,4,6-trimethylphenyl)-2-butanol 0,303-methyl-4- (2,4,6-trimethylphenyl) -2-butanol 0.30
4-(2,5-Dimethylphenyl)-3,3-dimethyl-2- - 0,30 butanol4- (2,5-dimethylphenyl) -3,3-dimethyl-2--0.30 butanol
3-Methyl 4-(3,4-dimethylphenyl)-2-butanol 0,303-methyl 4- (3,4-dimethylphenyl) -2-butanol 0.30
Parfüm, Konservierungsstoffe q.s. q.s. q.s.Perfume, preservatives q.s. q.s. q.s.
Wasser ad 100,00 ad 100,00 ad 100,00Water ad 100.00 ad 100.00 ad 100.00
Beispiel 3.9 SeifenstückExample 3.9 Soap bar
Na-Salz aus Taigfettsäuren 60,00 60,00 60,00 Na-Salz aus Kokosöl 28,00 28,00 28,00 Na salt from taig fatty acids 60.00 60.00 60.00 Na salt from coconut oil 28.00 28.00 28.00
Natriumchlorid 0,50 0,50 0,50Sodium chloride 0.50 0.50 0.50
4-(2,4,5-TrimethylphenyI)-3-methyl-2- 1,00 butanol4- (2,4,5-trimethylphenyl) -3-methyl-2- 1.00 butanol
4-(2,4,6-Trimethylphenyl)-2-butanol - 1,004- (2,4,6-trimethylphenyl) -2-butanol - 1.00
3,3-Dimethyl-4-(2,4,6-trimethylphenyl)-2- - - 1,00 butanol3,3-dimethyl-4- (2,4,6-trimethylphenyl) -2- - - 1.00 butanol
Parfüm, Konservierungsstoffe q.s. q.s. q.s.Perfume, preservatives q.s. q.s. q.s.
Wasser ad 100,00 ad 100,00 ad 100,00Water ad 100.00 ad 100.00 ad 100.00
Beispiel 3.10 SyndetseifeExample 3.10 Syndet soap
Natriumlaur Isulfat 30,00 30,00 30,00Sodium lauric isulfate 30.00 30.00 30.00
Natriumsulfosuccinat 10,00 10,00 10,00Sodium sulfosuccinate 10.00 10.00 10.00
Kaliumcocoyl hydrolysiertes Kollagen 2,00 2,00 2,00Potassium cocoyl hydrolyzed collagen 2.00 2.00 2.00
Dimethicon Copolyol 2,00 2,00 2,00Dimethicone Copolyol 2.00 2.00 2.00
Paraffin 2,00 2,00 2,00Paraffin 2.00 2.00 2.00
Maisstärke 10,00 10,00 10,00Corn starch 10.00 10.00 10.00
Talcum 10,00 10,00 10,00Talcum 10.00 10.00 10.00
Glycerin 3,00 3,00 3,00 Glycerin 3.00 3.00 3.00
3-Methyl- -(2,4,6-trimethylphenyl)-2-butanol 1 ,003-methyl- - (2,4,6-trimethylphenyl) -2-butanol 1, 00
4-(2,5-Dimethylphenyl)-3,3-dimethyl-2- 1,00 butanol4- (2,5-dimethylphenyl) -3,3-dimethyl-2- 1.00 butanol
3-Methyl 4-(3,4-dimethylphenyl)-2-butanol - - 1,003-methyl 4- (3,4-dimethylphenyl) -2-butanol - - 1.00
Parfüm, Konservierungsstoffe q.s. q.s. q.s.Perfume, preservatives q.s. q.s. q.s.
Wasser ad 100,00 ad 100,00 ad 100,00Water ad 100.00 ad 100.00 ad 100.00
Beispiel 3.11Example 3.11
Haarpflegemittel I II IIIHair care products I II III
TEA-Cocoyl hydrolysiertes Kollagen 30,00 30,00 30,00TEA cocoyl hydrolyzed collagen 30.00 30.00 30.00
Monoethanolaminlaurylsulfat 25,00 25,00 25,00Monoethanolamine lauryl sulfate 25.00 25.00 25.00
Mandelöl 2,00 2,00 2,00Almond oil 2.00 2.00 2.00
Natriumchlorid 1,00 1,00 1,00Sodium chloride 1.00 1.00 1.00
4-(3,4-Dimethylphenyl)-2-butanol 1,00 - -4- (3,4-dimethylphenyl) -2-butanol 1.00 - -
4-(4-t-Butylphenyl)-3-methyl-2-butanol - 1,00 -4- (4-t-butylphenyl) -3-methyl-2-butanol - 1.00 -
4-(4-lsobutylphenyl)-3-methyl-2-butanol - - 1,004- (4-isobutylphenyl) -3-methyl-2-butanol - - 1.00
Parfüm, Konservierungsstoffe q.s. q.s. q.s.Perfume, preservatives q.s. q.s. q.s.
Wasser ad 100,00 ad 100,00 ad 101 Water ad 100.00 ad 100.00 ad 101
Beispiel 3.12Example 3.12
Fflegeshampoo I II IIICare shampoo I II III
Natriumlaurylsulfat 34,00 34,00 34,00Sodium lauryl sulfate 34.00 34.00 34.00
Dinatriumlaurylsulfosuccinat 6,00 6,00 6,00Disodium lauryl sulfosuccinate 6.00 6.00 6.00
Cocoamidopropylbetain 10,00 10,00 10,00Cocoamidopropyl betaine 10.00 10.00 10.00
Glycoldistearat 5,00 5,00 5,00Glycol distearate 5.00 5.00 5.00
3-Methyl-(4-methylphenyl)-2-butanol 0,02 - -3-methyl- (4-methylphenyl) -2-butanol 0.02 - -
3-Methyl-(2-methylphenyl)-2-butanol - 1,00 -3-methyl- (2-methylphenyl) -2-butanol - 1.00 -
4-Bicydo[2.2.1]hept-2-yl-3-methyl-2- 1,00 butanol4-Bicydo [2.2.1] hept-2-yl-3-methyl-2- 1.00 butanol
Parfüm, Konservierungsstoffe q.s. q.s. q.s.Perfume, preservatives q.s. q.s. q.s.
Wasser ad 100,00 ad 100,00 ad 100,00Water ad 100.00 ad 100.00 ad 100.00
Beispiel 3.13Example 3.13
Haarspülung I II IIIHair conditioner I II III
Cocoamidopropylbetain 5,00 5,00 5,00Cocoamidopropyl betaine 5.00 5.00 5.00
Cetylalkohol 2,00 2,00 2,00Cetyl alcohol 2.00 2.00 2.00
Propylenglycol 2,00 2,00 2,00 Propylene glycol 2.00 2.00 2.00
Citronensäure 0,30 0,30 0,30Citric acid 0.30 0.30 0.30
4-BicycIo[2.2.1 ]hept-2-yl-2-butanol 1,004-Bicyclo [2.2.1] hept-2-yl-2-butanol 1.00
4-(2,6,6-Trimethylbicyclo[3.1.1]hept-3-yl)- 1,00 2-butanol4- (2,6,6-trimethylbicyclo [3.1.1] hept-3-yl) - 1.00 2-butanol
3-Methyl-6-phenyl-2-hexanol 1,003-methyl-6-phenyl-2-hexanol 1.00
Parfüm, Konservierungsstoffe q.s. q.s. q.s.Perfume, preservatives q.s. q.s. q.s.
Wasser ad 100,00 ad 100,00 ad 100,00Water ad 100.00 ad 100.00 ad 100.00
Beispiel 3.14 HaarfestigerExample 3.14 Hair Fixer
Polyvinylpyrrolidon/Vinylacetat/ 5,00 5,00 5,00Polyvinylpyrrolidone / vinyl acetate / 5.00 5.00 5.00
Vinylpropionat-CopolymerVinyl propionate copolymer
Ethanol 45,00 45,00 45,00Ethanol 45.00 45.00 45.00
6-(4-lsopropylphenyl)-3-methyl-2-hexanol 1,006- (4-isopropylphenyl) -3-methyl-2-hexanol 1.00
3,3-Dimethyl-4-pheπyl-2-butanol - 1,003,3-dimethyl-4-phenyl-2-butanol - 1.00
5,5-Dimethyl-6-(3-methylphenyl)-2- - - 1,00 hexanol5,5-dimethyl-6- (3-methylphenyl) -2- - - 1.00 hexanol
Parfüm, Konservierungsstoffe q.s. q.s. q.s. Wasser ad 100,00 ad 100,00 ad 100,00 Perfume, preservatives qsqsqs water ad 100.00 ad 100.00 ad 100.00
Beispiel 3-15 FußcremeExample 3-15 Foot Cream
Soluan 5 2,00 2,00 2,00Soluan 5 2.00 2.00 2.00
Methylsalicylat 5,00 5,00 5,00Methyl salicylate 5.00 5.00 5.00
Caprylic/Capric Triglyceride 10,00 10,00 10,00Caprylic / Capric Triglyceride 10.00 10.00 10.00
Stearinsäure 5,00 5,00 5,00Stearic acid 5.00 5.00 5.00
Cetylalkohol 1,00 1,00 1,00Cetyl alcohol 1.00 1.00 1.00
Glycerin 2,00 2,00 2,00Glycerin 2.00 2.00 2.00
Dimethicon 1,00 1,00 1,00Dimethicon 1.00 1.00 1.00
Carbopol 984 0,50 0,50 0,50Carbopol 984 0.50 0.50 0.50
Triethanolamin 1,50 1,50 1,50Triethanolamine 1.50 1.50 1.50
3-Methyl-4-(2,4-dimethyIphenyI)-2-butanol 1,00 - -3-methyl-4- (2,4-dimethylphenyI) -2-butanol 1.00 - -
4-(2,4-Dimelhylphenyl)-2-butanol - 1 ,00 -4- (2,4-dimethylphenyl) -2-butanol - 1.00 -
4-(2,4,5-Trimethylphenyl)-2-butanol - - 1,004- (2,4,5-trimethylphenyl) -2-butanol - - 1.00
Parfüm, Konservierungsstoffe q.s. q.s. q.s.Perfume, preservatives q.s. q.s. q.s.
Wasser ad 100,00 ad 100,00 ad 100,00 Water ad 100.00 ad 100.00 ad 100.00
Beispiel 3.16Example 3.16
Aerosolspray I II IIIAerosol spray I II III
Octyldodecanol 0,50 0,50 0,50Octyldodecanol 0.50 0.50 0.50
3-Methyl-4-(2,4,6-trimethyIphenyl)-2- 0,20 butanol3-methyl-4- (2,4,6-trimethylphenyl) -2-0.20 butanol
3-Methyl-4-(3,4-dimethylphenyl)-2-butanol - 0,203-methyl-4- (3,4-dimethylphenyl) -2-butanol - 0.20
4-(2,5-Dimethylphenyl)-3,3-dimethyl-2- - - 0,20 butanol4- (2,5-dimethylphenyl) -3,3-dimethyl-2- - - 0.20 butanol
Parfüm, Konservierungsstoffe q.s. q.s. q.s.Perfume, preservatives q.s. q.s. q.s.
Ethanol ad 100,00 ad 100,00 ad 100,00Ethanol ad 100.00 ad 100.00 ad 100.00
Die durch Zusammenmischung der jeweiligen Bestandteile erhaltene flüssige Phase wird zusammen mit einem Propan-Butan-Gemisch (2:7) im Verhältnis 39:61 in Aerosolbehälter abgefüllt-The liquid phase obtained by mixing the respective components together is filled into an aerosol container together with a propane-butane mixture (2: 7) in a ratio of 39:61.
Beispiel 3-17Example 3-17
Pumpspray I II IIIPump spray I II III
PEG-40-Hydriertes Rizinusöl 2,00 2,00 2,00PEG-40 hydrogenated castor oil 2.00 2.00 2.00
Glycerin 1,00 1,00 1,00 Glycerin 1.00 1.00 1.00
4-(3,4-Dimethylphenyl)-2-butanol 0,20 4-(4-t-Butylphenyl)-3-methyI-2-butanol 0,20 4-(4-lsobutylphenyl)-3-methyl-2-butanol 0,20 Parfüm, Konservierungsstoffe q.s. q.s. q.s. Wasser ad 100,00 ad 100,00 ad 100,004- (3,4-dimethylphenyl) -2-butanol 0.20 4- (4-t-butylphenyl) -3-methyl-2-butanol 0.20 4- (4-isobutylphenyl) -3-methyl-2- butanol 0.20 perfume, preservatives qs q.s. q.s. Water ad 100.00 ad 100.00 ad 100.00
Beispiel 3.18 Roll-on-GelExample 3.18 Roll-on-Gel
1 ,3-Butylenglycol 2,00 2,00 2,001,3-butylene glycol 2.00 2.00 2.00
PEG-40-Hydriertes Rizinusöl 2,00 2,00 2,00PEG-40 hydrogenated castor oil 2.00 2.00 2.00
Hydroxyethylcellulose 0,50 0,50 0,50Hydroxyethyl cellulose 0.50 0.50 0.50
4-(2,6,6-Trimethylbicyclo[3.1.1]hept-3-yl)-2- 0,30 butanol4- (2,6,6-trimethylbicyclo [3.1.1] hept-3-yl) -2-0.30 butanol
4-(2,4,6-Trimethylphenyl)-2-butanol - 0,304- (2,4,6-trimethylphenyl) -2-butanol - 0.30
4-(2,4,5-Trimethylphenyl)-3-methyl-2-butaπol - 0,304- (2,4,5-trimethylphenyl) -3-methyl-2-butaπol - 0.30
Parfüm, Konservierungsstoffe q.s. q.s. q.s.Perfume, preservatives q.s. q.s. q.s.
Wasser ad 100,00 ad 100,00 ad 100,00 Water ad 100.00 ad 100.00 ad 100.00
Beispiel 3.19Example 3.19
Gel-Zahncreme mit Wirksamkeit gegen Mundgeruch I (%) II (%) IM (%)Gel toothpaste with effectiveness against bad breath I (%) II (%) IM (%)
Na-carboxymethylcellulose 0,40 0,40 0,40Na carboxymethyl cellulose 0.40 0.40 0.40
Sorbitol, 70 % 72,00 72,00 72,00Sorbitol, 70% 72.00 72.00 72.00
PEG 1500 3,00 3,00 3,00PEG 1500 3.00 3.00 3.00
Na-saccharinat 0,07 0,07 0,07Na saccharinate 0.07 0.07 0.07
Na-fluorid 0,24 0,24 0,24Na fluoride 0.24 0.24 0.24
PHB-Ethylester 0,15 0,15 0,15PHB ethyl ester 0.15 0.15 0.15
Aroma 1,0 1,00 1,00Aroma 1.0 1.00 1.00
3-Methyl-6-phenyl-2-hexanol 0,50 1,50 3,003-methyl-6-phenyl-2-hexanol 0.50 1.50 3.00
Abrasivkieselsäure 11,00 11,00 11,00Abrasive silica 11.00 11.00 11.00
Verdickungskieselsäure 6,00 6,00 6,00Thickening silica 6.00 6.00 6.00
SDS 1,40 1,40 1,40SDS 1.40 1.40 1.40
Wasser dest. Ad 100,00 Ad 100,00 Ad 10(Distilled water Ad 100.00 Ad 100.00 Ad 10 (
Beispiel 3.20Example 3.20
Zahncreme gegen PIaque mit Wirksamkeit gegen Mundgeruch I (%) II (%) III (%)Toothpaste against PIaque with effectiveness against bad breath I (%) II (%) III (%)
Na-carboxymethylcellulose 1,00 1,00 1,00 Na carboxymethyl cellulose 1.00 1.00 1.00
Glycerin 86 % 12,50 12,50 12,50Glycerin 86% 12.50 12.50 12.50
Sorbitol 70 % 29,00 29,00 29,00Sorbitol 70% 29.00 29.00 29.00
Na-saccharinat 0,20 0,20 0,20Na saccharinate 0.20 0.20 0.20
Na-fluorid 0,22 0,22 0,22Na fluoride 0.22 0.22 0.22
AzacycIoheptan-2,2-diphosphosäure, 1,00 1,00 1,00AzacycIoheptan-2,2-diphosphonic acid, 1.00 1.00 1.00
Di- natriumsalz (AHP)Disodium salt (AHP)
Bromchlorophen 0,10 0,10 0,10Bromochlorophene 0.10 0.10 0.10
Aroma 1,10 1,10 1,10Aroma 1.10 1.10 1.10
3,3-Dimethy!-4-phenyl-2-butanol 0,50 1,50 3,003,3-Dimethy! -4-phenyl-2-butanol 0.50 1.50 3.00
Abrasivkieselsäure 15,00 15,00 15,00Abrasive silica 15.00 15.00 15.00
Verdickungskieselsäure 5,00 5,00 5,00Thickening silica 5.00 5.00 5.00
SDS 1,50 1,50 1 ,50SDS 1.50 1.50 1.50
Wasser dest. Ad 100,00 Ad 100,00 Ad 101Distilled water Ad 100.00 Ad 100.00 Ad 101
Beispiel 3.21Example 3.21
Zahncreme gegen PIaque mit Wirksamkeit gegen Mundgeruch I (%) II (%) III (%)Toothpaste against PIaque with effectiveness against bad breath I (%) II (%) III (%)
Carragenan 0,90 0,90 0,90Carragenan 0.90 0.90 0.90
Glycerin 86 % 15,00 15,00 15,00Glycerin 86% 15.00 15.00 15.00
Sorbitol 70 % 25,00 25,00 25,00 Sorbitol 70% 25.00 25.00 25.00
I (%) II (%) III (%)I (%) II (%) III (%)
PEG 1000 3,00 3,00 3,00PEG 1000 3.00 3.00 3.00
Na-fluorid 0,24 0,24 0,24Na fluoride 0.24 0.24 0.24
Tetra kalium-diphosphat 4,50 4,50 4,50Tetra potassium diphosphate 4.50 4.50 4.50
Tefranatrium-diphosphat 1,50 1,50 1,50Tefranosodium diphosphate 1.50 1.50 1.50
Na-saccharinat 0,40 0,40 0,40Na saccharinate 0.40 0.40 0.40
Fällungskieselsäure 20,00 20,00 20,00Precipitated silica 20.00 20.00 20.00
Titandioxid 1,00 1,00 1,00Titanium dioxide 1.00 1.00 1.00
PHB-Methylester 0,10 0,10 0,10PHB methyl ester 0.10 0.10 0.10
Aroma 1,10 1,10 1,10Aroma 1.10 1.10 1.10
3,3-DimethyI-4-phenyl-2- 0,50 1,50 3,00 butanol3,3-dimethyl-4-phenyl-2- 0.50 1.50 3.00 butanol
SDS 1,30 1,30 1,30SDS 1.30 1.30 1.30
Wasser dest. Ad 100,00 Ad 100,00 Ad 100,00Distilled water Ad 100.00 Ad 100.00 Ad 100.00
Beispiel 3.22Example 3.22
Zahncreme gegen empfindliche Zähne mit Wirksamkeit gegen Mundgeruch I (%) II (%) III (%)Toothpaste for sensitive teeth with effectiveness against bad breath I (%) II (%) III (%)
Na-carboxymethylcellulose 0,70 0,70 0,70Na carboxymethyl cellulose 0.70 0.70 0.70
Xanthan Gu 0,50 0,50 0,50 Xanthan Gu 0.50 0.50 0.50
I (%) II (%) III (%)I (%) II (%) III (%)
Glycerin 86 % 15,00 15,00 15,00Glycerin 86% 15.00 15.00 15.00
Sorbitol 70 % 12,00 12,00 12,00Sorbitol 70% 12.00 12.00 12.00
K-nitrat 5,00 5,00 5,00K-nitrate 5.00 5.00 5.00
Na-monofluorphosphat 0,80 0,80 0,80Na monofluorophosphate 0.80 0.80 0.80
PHB-Methylester 0,15 0,15 0,15PHB methyl ester 0.15 0.15 0.15
PHB-Propylester 0,05 0,05 0,05PHB propyl ester 0.05 0.05 0.05
Na-saccharinat 0,20 0,20 0,20Na saccharinate 0.20 0.20 0.20
Aroma 1,00 1,00 1,00Aroma 1.00 1.00 1.00
4-Bicyclo[2-2- 1 ]hept-2-yl-2- 0,50 1,50 3,00 butanol4-bicyclo [2-2-1] hept-2-yl-2- 0.50 1.50 3.00 butanol
Ca-carbonat 35,00 35,00 35,00Ca carbonate 35.00 35.00 35.00
Siliciumdioxid 1,00 1,00 1,00Silicon 1.00 1.00 1.00
SDS 1,50 1,50 1,50SDS 1.50 1.50 1.50
Wasser dest. Ad 100,00 Ad 100,00 Ad 100,00Distilled water Ad 100.00 Ad 100.00 Ad 100.00
Beispiel 3.23Example 3.23
Mundwasser mit Fluorid und Wirksamkeit gegen Mundgeruch I (%) II (%) III (%)Mouthwash with fluoride and effectiveness against bad breath I (%) II (%) III (%)
EthanoI 94,7 % 7,00 7,00 7,00 EthanoI 94.7% 7.00 7.00 7.00
Glycerin 86 % 12,00 12,00 12,00Glycerin 86% 12.00 12.00 12.00
Na-fluorid 0,05 0,05 0,05Na fluoride 0.05 0.05 0.05
Pluronic F-127 1 ,40 1,40 1,40Pluronic F-127 1, 40 1.40 1.40
Na-phosphatpuffer pH 7,0 1,10 1,10 1,10Na phosphate buffer pH 7.0 1.10 1.10 1.10
Sorbinsäure 0,20 0,20 0,20Sorbic acid 0.20 0.20 0.20
Na-saccharinat 0,10 0,10 0,10Na saccharinate 0.10 0.10 0.10
Aroma 0,15 0,15 0,15Aroma 0.15 0.15 0.15
4-(2,4,5-Trimethylphenyl)- 0,10 0,20 0,404- (2,4,5-trimethylphenyl) - 0.10 0.20 0.40
2-butanol2-butanol
Farbstoff 0,01 0,01 0,01Dye 0.01 0.01 0.01
Wasser dest. Ad 100,00 Ad 100,00 Ad 100,00Distilled water Ad 100.00 Ad 100.00 Ad 100.00
Beispiel 3.24Example 3.24
Kaugummi gegen Mundgeruch I (%) II (%) III (%)Bad breath chewing gum I (%) II (%) III (%)
Kaugummibase 21,00 21,00 21,00Chewing gum base 21.00 21.00 21.00
Glucose Sirup 16,50 16,50 16,50Glucose syrup 16.50 16.50 16.50
Glycerin 0,50 0,50 0,50Glycerin 0.50 0.50 0.50
Puderzucker 60,00 59,00 57,50Icing sugar 60.00 59.00 57.50
Aroma 1,50 1,50 1,50 Aroma 1.50 1.50 1.50
3-Methyl-(2- 0,50 1,50 3,00 methylphenyl)-2-butanol3-methyl- (2- 0.50 1.50 3.00 methylphenyl) -2-butanol
Beispiel 3-25Example 3-25
Zuckerfreier Kaugummi gegen Mundgeruch l (%) II (%) III (%)Sugar-free chewing gum for bad breath l (%) II (%) III (%)
Kaugummibase 30,00 30,00 30,00Chewing gum base 30.00 30.00 30.00
Sorbit pulv. 38,00 37,00 35,50Sorbitol powder. 38.00 37.00 35.50
Palatinit 9,50 9,50 9,50Palatinite 9.50 9.50 9.50
Xyiit 2,00 2,00 2,00Xyiite 2.00 2.00 2.00
Mannit 3,00 3,00 3,00Mannitol 3.00 3.00 3.00
Aspartame 0,10 0,10 0,10Aspartame 0.10 0.10 0.10
Acesulfam K 0,10 0,10 0,10Acesulfame K 0.10 0.10 0.10
Emulgum / Emulgator 0,30 0,30 0,30Emulsifier / emulsifier 0.30 0.30 0.30
Sorbitol 70% 14,00 14,00 14,00Sorbitol 70% 14.00 14.00 14.00
Glycerin 1,00 1,00 1,00Glycerin 1.00 1.00 1.00
Aroma 1,50 1,50 1,50Aroma 1.50 1.50 1.50
6-(4-lsopropylphenyl)-3- 0,50 1,50 3,00 methyl-2-hexanol 6- (4-isopropylphenyl) -3- 0.50 1.50 3.00 methyl-2-hexanol
Beispiel 3-36 „Wasser in ÖI"-Emulsion mit UVA/B-BreitbandschutzExample 3-36 "Water in Oil" Emulsion with UVA / B Broadband Protection
Figure imgf000057_0001
Figure imgf000057_0001
Figure imgf000058_0001
Figure imgf000058_0001
Figure imgf000059_0001
Für Teil A wurden alle Substanzen bis auf das Zinkoxid auf 85°C erhitzt und das Zinkoxid in der Mischung sorgfältig dispergiert. Die Komponenten des Teils B wurde gemischt, auf 85°C erhitzt und unter Rühren zu Teil A gegeben. Zu der Mischung aus den Teilen A und B wurde Teil C zugegeben und anschließend die Mischung mit einem Dispergierwerkzeug homogenisiert.
Figure imgf000059_0001
For part A, all substances except the zinc oxide were heated to 85 ° C. and the zinc oxide was carefully dispersed in the mixture. The components of Part B were mixed, heated to 85 ° C and added to Part A with stirring. Part C was added to the mixture of parts A and B and the mixture was then homogenized using a dispersing tool.

Claims

Ansprüche Expectations
1. Verwendung einer Verbindung der Formel I1. Use of a compound of formula I.
Figure imgf000060_0001
als Wirkstoff gegen Gram-positive Bakterien, worin m und n unabhängig voneinander 0 und 1 bedeuten,
Figure imgf000060_0001
as an active ingredient against Gram-positive bacteria, where m and n are independently 0 and 1,
R1 bis R6 unabhängig voneinander Wasserstoff oder Methyl bedeuten undR 1 to R 6 are independently hydrogen or methyl and
A eine Phenylgruppe, die gegebenenfalls mit weiteren C bis C5- Alkylsubstituenten substituiert ist, eine Norboran-2-yI- oder eine Pinan-3- yl-Gruppe ist.A is a phenyl group which is optionally substituted by further C to C 5 alkyl substituents, a norboran-2-yI or a pinan-3-yl group.
2. Verwendung nach Anspruch 1, wobei mindestens eine in der Verbindung vorhandene Gruppe R1 bis R6 Methyl ist, falls A eine Phenylgruppe oder eine monoalkylsubstituierte Phenylgruppe ist.2. Use according to claim 1, wherein at least one group R 1 to R 6 present in the compound is methyl if A is a phenyl group or a monoalkyl-substituted phenyl group.
3. Verwendung nach einem der vorangehenden Ansprüche, wobei die Gram-positiven Bakterien ausgewählt sind aus der Gruppe, die besteht aus: (a) Körpergeruch verursachenden, (b) unreine Haut und/oder Akne verursachenden, (c) Mundgeruch und/oder schlechten Atem verursachenden Bakterien.3. Use according to one of the preceding claims, wherein the gram-positive bacteria are selected from the group consisting of: (a) body odor causing, (b) impure skin and / or acne causing, (c) bad breath and / or bad Respiratory bacteria.
4. Verwendung nach einem der vorangehenden Ansprüche, wobei die Gram-positiven Bakterien ausgewählt sind aus der Gruppe von4. Use according to one of the preceding claims, wherein the Gram-positive bacteria are selected from the group of
Körpergeruch verursachenden Bakterien, die aus Bakterien der Gattungen Corynebacterium, Staphyiococcus, Micrococcus und Brevibacterium besteht, insbesondere Corynebacterium xerosis, Bacteria causing body odor, which consists of bacteria of the genera Corynebacterium, Staphyiococcus, Micrococcus and Brevibacterium, in particular Corynebacterium xerosis,
Staphylococcus epidermidis, Staphyiococcus hominis, Micrococcus luteus, Micrococcus sedentarius und Brevibacterium epidermidis.Staphylococcus epidermidis, Staphyiococcus hominis, Micrococcus luteus, Micrococcus sedentarius and Brevibacterium epidermidis.
5. Verwendung nach einem der Ansprüche 1 - 3, wobei die Grampositiven Bakterien ausgewählt sind aus der Gruppe von unreine Haut und/oder Akne verursachenden Bakterien der Gattung Propionibacterium, insbesondere Propionibacterium acnes.5. Use according to one of claims 1-3, wherein the gram-positive bacteria are selected from the group of impure skin and / or acne-causing bacteria of the genus Propionibacterium, in particular Propionibacterium acnes.
6. Verwendung nach einem der Ansprüche 1 - 3, wobei die Grampositiven Bakterien ausgewählt sind aus der Gruppe von Mundgeruch und/oder schlechten Atem verursachenden Bakterien der Gattungen Actinomyces, Eubacterium, Rothia und Stomatococcus, insbesondere Actinomyces viscosus, Eubacterium brachy, Eubacterium nodatum, Eubacterium saburreum, Eubacterium timidum Eubacterium yurrii, Rothia denticariosus und Stomatococcus mucilaginosus.6. Use according to any one of claims 1-3, wherein the gram-positive bacteria are selected from the group of bad breath and / or bad breath-causing bacteria of the genera Actinomyces, Eubacterium, Rothia and Stomatococcus, in particular Actinomyces viscosus, Eubacterium brachy, Eubacterium nodatum, Eubacterium saburreum, Eubacterium timidum Eubacterium yurrii, Rothia denticariosus and Stomatococcus mucilaginosus.
7. Verwendung nach einem der vorangehenden Ansprüche, wobei für die Verbindung der Formel I zusätzlich gilt: m + n -= 0 oder 2.7. Use according to one of the preceding claims, wherein the following also applies to the compound of the formula I: m + n - = 0 or 2.
8. Verwendung nach einem der vorangehenden Ansprüche, wobei die Verbindung der Formel I zumindest drei CH3 - Gruppen besitzt.8. Use according to one of the preceding claims, wherein the compound of formula I has at least three CH 3 groups.
9. Verfahren zur Bekämpfung Gram-positiver Bakterien, wobei die Bakterien mit einer antimikrobiell wirksamen Menge einer Verbindung der Formel I gemäß Anspruch 1 oder einer Mischung von zumindest zwei unterschiedlichen Verbindungen der Formel I gemäß Anspruch 1 kontaktiert werden.9. A method for controlling Gram-positive bacteria, the bacteria being contacted with an antimicrobially effective amount of a compound of the formula I according to claim 1 or a mixture of at least two different compounds of the formula I according to claim 1.
10. Verfahren zur Bekämpfung von (a) durch Gram-positive Bakterien verursachtem Körpergeruch (b) durch Gram-positive Bakterien verursachte unreiner Haut und/oder Akne und/oder (c) durch Gram- positive Bakterien verursachtem Mundgeruch und/oder schlechten Atem, wobei die Gram-positiven Bakterien mit einer antimikrobiell 10. A method for controlling (a) body odor caused by Gram-positive bacteria (b) impure skin and / or acne caused by Gram-positive bacteria and / or (c) bad breath and / or bad breath caused by Gram-positive bacteria, taking the gram-positive bacteria with an antimicrobial
wirksamen Menge einer Verbindung der Formel I gemäß Anspruch 1 oder einer Mischung von zumindest zwei unterschiedlichen Verbindungen der Formel I gemäß Anspruch 1 kontaktiert werden.effective amount of a compound of formula I according to claim 1 or a mixture of at least two different compounds of formula I according to claim 1 can be contacted.
11. 4-(2,4,5-Trimethylphenyl)-2-butanol (Verbindung 14), 3-Methyl-4- (2,4,5-trimethylphenyl)-2-butanol (Verbindung 4), 4-(4-lsopropylphenyl)- 3-methyl-2-butanol (Verbindung 11), 4-(4-lsobutylphenyl)-3-methyl-2- butanol (Verbindung 6), 3-Methyl-4-(2,4,6-trimethylphenyi)-2-butanol (Verbindung 8), 4-(3,4-DimethyIphenyl)-3-methyl-2-butanol (Verbindung 17), 4-(3,4-Dimethylphenyl)-2-butanol (Verbindung 18), 4-(2,4- Dimethylphenyl)-3-methyl-2-butanol (Verbindung 12), 4-(2,4- Dimethylphenyl)-2-butanoI (Verbindung 13).11. 4- (2,4,5-Trimethylphenyl) -2-butanol (Compound 14), 3-methyl-4- (2,4,5-trimethylphenyl) -2-butanol (Compound 4), 4- (4 -Isopropylphenyl) - 3-methyl-2-butanol (compound 11), 4- (4-isobutylphenyl) -3-methyl-2-butanol (compound 6), 3-methyl-4- (2,4,6-trimethylphenyi ) -2-butanol (compound 8), 4- (3,4-dimethylphenyl) -3-methyl-2-butanol (compound 17), 4- (3,4-dimethylphenyl) -2-butanol (compound 18), 4- (2,4-dimethylphenyl) -3-methyl-2-butanol (compound 12), 4- (2,4-dimethylphenyl) -2-butanoI (compound 13).
12. Zubereitung, umfassend eine antibakteriell wirksame Menge einer Verbindung nach Anspruch 11, sowie zumindest einen weiteren Bestandteil.12. A preparation comprising an antibacterially effective amount of a compound according to claim 11, and at least one further component.
13. Verfahren zum Verhindern des Befalls einer kosmetischen Substanz oder Formulierung mit grampositiven Bakterien, wobei die Substanz oder Formulierung mit einer antibaicteriell wirksamen Menge einer oder mehrerer Verbindungen der Formel I nach Anspruch 1 vermischt wird. 13. A method for preventing the infestation of a cosmetic substance or formulation with gram-positive bacteria, the substance or formulation being mixed with an antibacterially effective amount of one or more compounds of the formula I according to claim 1.
PCT/EP2004/051078 2003-07-08 2004-06-09 Secondary alcohols used as antimicrobial agents WO2005004601A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP04741770A EP1651037A1 (en) 2003-07-08 2004-06-09 Secondary alcohols used as antimicrobial agents

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10330697.8 2003-07-08
DE2003130697 DE10330697A1 (en) 2003-07-08 2003-07-08 Secondary alcohols as antimicrobial agents

Publications (1)

Publication Number Publication Date
WO2005004601A1 true WO2005004601A1 (en) 2005-01-20

Family

ID=33559952

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2004/051078 WO2005004601A1 (en) 2003-07-08 2004-06-09 Secondary alcohols used as antimicrobial agents

Country Status (3)

Country Link
EP (1) EP1651037A1 (en)
DE (1) DE10330697A1 (en)
WO (1) WO2005004601A1 (en)

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1738803A1 (en) * 2005-03-16 2007-01-03 Henkel Kommanditgesellschaft auf Aktien Inhibitors of staphylococcus hominis in deodorants and antiperspirants
DE102008043586A1 (en) 2007-11-12 2009-05-14 Symrise Gmbh & Co. Kg Perfume Accords to combat the perception of body odor
EP2133102A1 (en) 2008-03-19 2009-12-16 Symrise GmbH & Co. KG Odor reducers
WO2011006689A3 (en) * 2009-07-16 2012-03-29 Henkel Ag & Co. Kgaa Cosmetic and dermatological topical compositions having a hair growth-minimising or hair growth-inhibiting effect
EP2662434A1 (en) 2012-05-10 2013-11-13 Symrise AG Use of specific compounds for enhancing odours
US8623340B2 (en) 2009-04-28 2014-01-07 Symrise Ag Omega-cyclohexylalkan-1-oles and use thereof as antimicrobial actives to combat body odor
US8911715B2 (en) 2008-05-30 2014-12-16 Symrise Ag L-menthyl-N-(2-hydroxyphenyl)carbamate
WO2015002095A1 (en) * 2013-07-02 2015-01-08 花王株式会社 Irritation relieving agent
EP2966158A1 (en) 2014-07-07 2016-01-13 Symrise AG Isomers mixtures of unsaturated macrocyclic musk compounds
EP2966159A1 (en) 2014-07-07 2016-01-13 Symrise AG Mixtures with enriched e-isomers of unsaturated macrocyclic musk compounds
US20160264910A1 (en) * 2013-11-08 2016-09-15 Firmenich Sa Alcohol with floral odor
WO2020098923A1 (en) 2018-11-13 2020-05-22 Symrise Ag Perfuming ingredients with lily of the valley note
WO2020098901A1 (en) 2018-11-12 2020-05-22 Symrise Ag Use of 1-ethyl-4,4-dimethyl-cyclohexane derivatives as fragrances
WO2020125993A1 (en) 2018-12-20 2020-06-25 Symrise Ag Alicyclic musk fragrance compounds
WO2022194957A1 (en) 2021-03-19 2022-09-22 Firmenich Sa Antimicrobial perfuming consumer products
WO2023213381A1 (en) 2022-05-03 2023-11-09 Symrise Ag Novel fragrance compounds

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2168570B1 (en) 2008-09-30 2013-12-25 Symrise AG Extracts of isochrysis sp.
EP2193785B1 (en) 2008-12-05 2018-07-18 Symrise AG Extracts of Tetraselmis sp. for cosmetic and therapeutic purposes
EP3045161A1 (en) 2015-01-18 2016-07-20 Symrise AG Active compositions comprising 1,2-hexanediol and 1,2-octanediol

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4006218A (en) * 1974-07-08 1977-02-01 Johnson & Johnson Potentiated medicaments
WO1993001714A1 (en) * 1991-07-25 1993-02-04 Henkel Kommanditgesellschaft Auf Aktien Mixtures with an antimicrobial action

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4006218A (en) * 1974-07-08 1977-02-01 Johnson & Johnson Potentiated medicaments
WO1993001714A1 (en) * 1991-07-25 1993-02-04 Henkel Kommanditgesellschaft Auf Aktien Mixtures with an antimicrobial action

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1738803A1 (en) * 2005-03-16 2007-01-03 Henkel Kommanditgesellschaft auf Aktien Inhibitors of staphylococcus hominis in deodorants and antiperspirants
DE102008043586A1 (en) 2007-11-12 2009-05-14 Symrise Gmbh & Co. Kg Perfume Accords to combat the perception of body odor
EP2133102A1 (en) 2008-03-19 2009-12-16 Symrise GmbH & Co. KG Odor reducers
US8852565B2 (en) 2008-03-19 2014-10-07 Symrise Ag Odour-reducing substances
US8911715B2 (en) 2008-05-30 2014-12-16 Symrise Ag L-menthyl-N-(2-hydroxyphenyl)carbamate
US8623340B2 (en) 2009-04-28 2014-01-07 Symrise Ag Omega-cyclohexylalkan-1-oles and use thereof as antimicrobial actives to combat body odor
WO2011006689A3 (en) * 2009-07-16 2012-03-29 Henkel Ag & Co. Kgaa Cosmetic and dermatological topical compositions having a hair growth-minimising or hair growth-inhibiting effect
EP2662434A1 (en) 2012-05-10 2013-11-13 Symrise AG Use of specific compounds for enhancing odours
EP2662098A1 (en) 2012-05-10 2013-11-13 Symrise AG Use of specific compounds for changing odours
WO2015002095A1 (en) * 2013-07-02 2015-01-08 花王株式会社 Irritation relieving agent
US9982218B2 (en) * 2013-11-08 2018-05-29 Firmenich Sa Alcohol with floral odor
US20160264910A1 (en) * 2013-11-08 2016-09-15 Firmenich Sa Alcohol with floral odor
US10370616B2 (en) 2013-11-08 2019-08-06 Firmenich Sa Alcohol with floral odor
EP2966159A1 (en) 2014-07-07 2016-01-13 Symrise AG Mixtures with enriched e-isomers of unsaturated macrocyclic musk compounds
WO2016005361A1 (en) 2014-07-07 2016-01-14 Symrise Ag Isomer mixtures of unsaturated macrocyclic musk compounds
WO2016005360A1 (en) 2014-07-07 2016-01-14 Symrise Ag Mixtures having enriched e-isomers of unsaturated macrocyclic musk compounds
EP2966158A1 (en) 2014-07-07 2016-01-13 Symrise AG Isomers mixtures of unsaturated macrocyclic musk compounds
EP4006130A1 (en) 2014-07-07 2022-06-01 Symrise AG Isomer mixtures of unsaturated macrocyclic musk compounds
WO2020098901A1 (en) 2018-11-12 2020-05-22 Symrise Ag Use of 1-ethyl-4,4-dimethyl-cyclohexane derivatives as fragrances
WO2020098923A1 (en) 2018-11-13 2020-05-22 Symrise Ag Perfuming ingredients with lily of the valley note
WO2020125993A1 (en) 2018-12-20 2020-06-25 Symrise Ag Alicyclic musk fragrance compounds
WO2022194957A1 (en) 2021-03-19 2022-09-22 Firmenich Sa Antimicrobial perfuming consumer products
WO2023213381A1 (en) 2022-05-03 2023-11-09 Symrise Ag Novel fragrance compounds

Also Published As

Publication number Publication date
EP1651037A1 (en) 2006-05-03
DE10330697A1 (en) 2005-02-03

Similar Documents

Publication Publication Date Title
EP2455157B1 (en) Solubilizer for cosmetic preparations
WO2005004601A1 (en) Secondary alcohols used as antimicrobial agents
EP1187598B1 (en) Micropigment mixture
EP2488257B1 (en) Formulation with irritation reducing action comprising bisabolol and [6]-paradol
EP0742004B1 (en) Substances effective against bacteria and mycosis
EP1909747A1 (en) Dermocosmetic preparations
WO2008025755A1 (en) Use of n-containing heterocycles in dermocosmetics
KR20080079300A (en) Stabilizing composition
EP0869797A2 (en) Use of sugar derivatives as antimicrobial, antimycotic and/or antiviral active substances
DE19634019A1 (en) Antimicrobial, antiviral, antiparasitic and antiprotozoal agents
DE10025124B4 (en) Combinations of glycerol monoalkyl ethers and aryl-substituted alcohols
WO2014139758A1 (en) Compositions consisting of alkylamidothiazoles and aromatic substances
EP2322138A2 (en) Antimicrobial composition
EP1539128B1 (en) Use of skin-protecting substances
EP1066821A1 (en) Topical cosmetic product containing benzaldoxims
DE102006034320A1 (en) Antioxidant, useful for preparation of e.g. coloring agent, vesicle, dermocosmetic, pharmaceuticals and nutrient- or feedstuff, comprises at least an isorenieratene compound
DE19634021A1 (en) Microbial adhesion inhibitor comprising glyco:glycero:lipid
EP1881817A2 (en) Use of peroxide decomposers in cosmetic and pharmaceutical agents for treating skin
WO2005037239A2 (en) Use of a compound from the group of heterodiazoles or a salt of said compound, cosmetic or therapeutic formulation containing said compound or salt, said compound or salt as a therapeutic agent, and said salt
US9066880B2 (en) Use of dihydrodehydrodiisoeugenol and preparations comprising dihydrodehydrodiisoeugenol
DE202021004361U1 (en) Multifunctional mixtures containing several (bio)alkanediols
EP2094641B1 (en) Dialkyl carbonates of branched alcohols and their use
JP4053966B2 (en) Skin external preparation and skin irritation relieving agent
DE102009018334A1 (en) Use of glycyrrhetinic acid and / or derivatives for the preparation of cosmetic or dermatological preparations for the prophylaxis of damage to the skin's own DNA and / or for the repair of already occurred damage to the DNA of its own today
DE102006051088A1 (en) Antioxidant, useful in the preparation of a dyeing agent, vesicle, carotenoid formulation, dermocosmetic, pharmaceutical, food, feed, gelatin capsule and/or solid- or liquid material, comprises an isorenieratene compound

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2004741770

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2004741770

Country of ref document: EP